Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Jan. 03, 2021 | Mar. 15, 2021 | Jun. 28, 2020 | |
Document Information [Line Items] | |||
Entity Central Index Key | 0000882508 | ||
Entity Registrant Name | QUICKLOGIC Corp | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --01-03 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2020 | ||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Jan. 3, 2021 | ||
Document Transition Report | false | ||
Entity File Number | 000-22671 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 77-0188504 | ||
Entity Address, Address Line One | 2220 Lundy Avenue | ||
Entity Address, City or Town | San Jose | ||
Entity Address, State or Province | CA | ||
Entity Address, Postal Zip Code | 95131 | ||
City Area Code | 408 | ||
Local Phone Number | 990-4000 | ||
Title of 12(b) Security | Common Stock, $0.001 par value | ||
Trading Symbol | QUIK | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 33,481,698 | ||
Entity Common Stock, Shares Outstanding | 11,270,290 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Jan. 03, 2021 | Dec. 29, 2019 |
Current assets: | ||
Cash and cash equivalents and restricted cash | $ 22,748 | $ 21,548 |
Accounts receivable, net of allowances for doubtful accounts of $0 | 1,688 | 1,991 |
Inventories | 2,688 | 3,260 |
Other current assets | 1,066 | 1,565 |
Total current assets | 28,190 | 28,364 |
Property and equipment, net | 548 | 830 |
Capitalized internal-use software, net | 986 | 333 |
Right of use assets, net | 1,839 | 2,370 |
Intangible assets, net | 860 | 1,008 |
Goodwill | 185 | 185 |
Other assets | 280 | 314 |
TOTAL ASSETS | 32,888 | 33,404 |
Current liabilities: | ||
Revolving line of credit | 15,000 | 15,000 |
Trade payables | 935 | 1,003 |
Accrued liabilities | 1,340 | 1,133 |
Deferred revenue | 52 | 158 |
Lease liabilities, current | 685 | 704 |
Total current liabilities | 18,012 | 17,998 |
Long-term liabilities: | ||
Lease liabilities, non-current | 1,197 | 1,583 |
Paycheck Protection Program loan | 1,192 | 0 |
Total liabilities | 20,401 | 19,581 |
Commitments (Note 15) | ||
Stockholders' equity: | ||
Preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued or outstanding | 0 | 0 |
Common stock, $0.001 par value; 200,000 shares authorized; 11,094 and 8,331 shares issued and outstanding as of January 3, 2021 and December 29, 2019, respectively | 11 | 8 |
Additional paid-in capital | 306,885 | 297,073 |
Accumulated deficit | (294,409) | (283,258) |
Total stockholders' equity | 12,487 | 13,823 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 32,888 | $ 33,404 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parentheticals) - USD ($) shares in Thousands, $ in Thousands | Jan. 03, 2021 | Dec. 29, 2019 |
Allowance for doubtful accounts | $ 0 | $ 0 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 10,000 | 10,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 200,000 | 200,000 |
Common stock, shares issued (in shares) | 11,094 | 8,331 |
Common stock, shares outstanding (in shares) | 11,094 | 8,331 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Thousands | 12 Months Ended | |||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | ||
Revenue | [1] | $ 8,634,000 | $ 10,310,000 | $ 12,629,000 |
Cost of revenue | 4,386,000 | 4,405,000 | 6,295,000 | |
Gross profit | 4,248,000 | 5,905,000 | 6,334,000 | |
Operating expenses: | ||||
Research and development | 7,544,000 | 12,350,000 | 9,948,000 | |
Selling, general and administrative | 6,820,000 | 8,918,000 | 9,982,000 | |
Restructuring costs | 753,000 | 0 | 0 | |
Loss from operations | (10,869,000) | (15,363,000) | (13,596,000) | |
Interest expense | (328,000) | (350,000) | (108,000) | |
Interest income and other expense, net | 97,000 | 189,000 | 77,000 | |
Loss before income taxes | (11,100,000) | (15,524,000) | (13,627,000) | |
Provision for (benefit from) income taxes | 51,000 | (80,000) | 152,000 | |
Net loss | $ (11,151,000) | $ (15,444,000) | $ (13,779,000) | |
Net loss per share: (1) | ||||
Basic and diluted (in dollars per share) | [2] | $ (1.14) | $ (2.02) | $ (2.16) |
Weighted average shares: (1) | ||||
Basic and diluted (in shares) | [2] | 9,781 | 7,663 | 6,365 |
[1] | New products include all products manufactured on 180 nanometer or smaller semiconductor processes, eFPGA IP license, QuickAI and SensiML AI software as a service (SaaS) revenues. Mature products include all products produced on semiconductor processes larger than 180 nanometer. | |||
[2] | Net loss per share and weighted average shares, basic and diluted are adjusted to reflect 1-for-14 reverse stock split effected on December 23, 2019. |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 29, 2019 | Dec. 30, 2018 | |
Cash flows from operating activities: | ||||
Net loss | $ (11,151,000) | $ (15,444,000) | $ (13,779,000) | |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||
Depreciation and amortization | 817,000 | 1,201,000 | 1,276,000 | |
Stock-based compensation | 1,739,000 | 3,144,000 | 1,901,000 | |
Write-down of inventories | 199,000 | 94,000 | 386,000 | |
Write-off of equipment | 44,000 | 4,000 | 5,000 | |
Tax benefit from acquisition | 0 | (185,000) | 0 | |
Gain on disposal of assets | 0 | 0 | (62,000) | |
Changes in operating assets and liabilities: | ||||
Accounts receivable | 303,000 | 218,000 | (1,284,000) | |
Inventories | 373,000 | 483,000 | (662,000) | |
Other assets | 533,000 | 229,000 | (879,000) | |
Trade payables | 298,000 | (456,000) | 223,000 | |
Accrued liabilities | 207,000 | (1,024,000) | 235,000 | |
Deferred income | (106,000) | 158,000 | 0 | |
Other long-term liabilities | 0 | (16,000) | 2,000 | |
Net cash used in operating activities | (6,744,000) | (11,594,000) | (12,638,000) | |
Cash flows from investing activities: | ||||
Capital expenditures for property and equipment | (253,000) | (576,000) | (351,000) | |
Capitalized internal-use software | (801,000) | (365,000) | 0 | |
Cash received from business acquisition | 0 | 20,000 | 0 | |
Proceeds from sale of assets | 0 | 0 | 63,000 | |
Net cash used in investing activities | (1,054,000) | (921,000) | (288,000) | |
Cash flows from financing activities: | ||||
Payment of finance lease obligations | (270,000) | $ (365,000) | (365,000) | (407,000) |
Proceeds from Paycheck Protection Program loan | 1,191,000 | 0 | 0 | |
Proceeds from line of credit | 57,000,000 | 46,000,000 | 36,000,000 | |
Repayment of line of credit | (57,000,000) | (46,000,000) | (27,000,000) | |
Proceeds from issuance of common stock | 9,296,000 | 9,437,000 | 16,215,000 | |
Stock issuance costs | (1,147,000) | (1,181,000) | (1,638,000) | |
Taxes paid related to net settlement of equity awards | (72,000) | (291,000) | (308,000) | |
Net cash provided by financing activities | 8,998,000 | 7,600,000 | 22,862,000 | |
Net (decrease) increase in cash, cash equivalents and restricted cash | 1,200,000 | (4,915,000) | 9,936,000 | |
Cash, cash equivalents and restricted cash at the beginning of the period | 21,548,000 | 26,463,000 | 16,527,000 | |
Cash, cash equivalents, and restricted cash at the end of the period | 22,748,000 | $ 21,548,000 | 21,548,000 | 26,463,000 |
Supplemental disclosures of cash flow information: | ||||
Interest paid | 277,000 | 300,000 | 89,000 | |
Income taxes paid | 24,000 | 126,000 | 171,000 | |
Fair value of common stock issued as consideration for business acquisition | 0 | 903,000 | 0 | |
Finance lease obligation to finance capital expenditures | 670,000 | 471,000 | 424,000 | |
Purchase of equipment included in accounts payable | $ 0 | $ 0 | $ 5,000 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total | ||
Balance (in shares) at Dec. 31, 2017 | [1] | 5,753,000 | ||||
Balance at Dec. 31, 2017 | $ 6 | [1] | $ 268,907 | $ (254,035) | $ 14,878 | |
Common stock issued under stock plans and employee stock purchase plans (in shares) | [1] | 105 | ||||
Common stock issued under stock plans and employee stock purchase plans | $ 0 | [1] | 353 | 0 | 353 | |
Common stock offering, net of issuance costs (in shares) | [1] | 965,000 | ||||
Common stock offering, net of issuance costs | $ 1 | [1] | 13,901 | 0 | 13,902 | |
Stock-based compensation | 0 | [1] | 1,901 | 0 | 1,901 | |
Net loss | $ 0 | [1] | 0 | (13,779) | (13,779) | |
Balance (in shares) at Dec. 30, 2018 | [1] | 6,823,000 | ||||
Balance at Dec. 30, 2018 | $ 7 | [1] | 285,062 | (267,814) | 17,255 | |
Common stock issued under stock plans and employee stock purchase plans (in shares) | [1] | 110,000 | ||||
Common stock issued under stock plans and employee stock purchase plans | $ 0 | [1] | (37) | 0 | (37) | |
Common stock offering, net of issuance costs (in shares) | [1] | 1,314,000 | ||||
Common stock offering, net of issuance costs | $ 1 | [1] | 8,001 | 0 | 8,002 | |
Stock-based compensation | 0 | [1] | 3,144 | 0 | 3,144 | |
Net loss | $ 0 | [1] | 0 | (15,444) | (15,444) | |
Common stock issued for SensiML acquisition (in shares) | [1] | 84,000 | ||||
Common stock issued for SensiML acquisition | $ 0 | [1] | 903 | 0 | 903 | |
Balance (in shares) at Dec. 29, 2019 | [1] | 8,331,000 | ||||
Balance at Dec. 29, 2019 | $ 8 | [1] | 297,073 | (283,258) | 13,823 | |
Common stock issued under stock plans and employee stock purchase plans (in shares) | [1] | 121,000 | ||||
Common stock issued under stock plans and employee stock purchase plans | $ 0 | [1] | (24) | 0 | (24) | |
Common stock offering, net of issuance costs (in shares) | [1] | 2,642,000 | ||||
Common stock offering, net of issuance costs | $ 3 | [1] | 8,097 | 0 | 8,100 | |
Stock-based compensation | 0 | [1] | 1,739 | 0 | 1,739 | |
Net loss | $ 0 | [1] | 0 | (11,151) | (11,151) | |
Balance (in shares) at Jan. 03, 2021 | [1] | 11,094,000 | ||||
Balance at Jan. 03, 2021 | $ 11 | [1] | $ 306,885 | $ (294,409) | $ 12,487 | |
[1] | Common stock, par value and additional paid-in capital amounts are adjusted to reflect 1-for-14 reverse stock split effected on December 23, 2019. |
Note 1 - The Company and Basis
Note 1 - The Company and Basis of Presentation | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] | 1 QuickLogic Corporation, ("QuickLogic" or, the "Company"), was founded in 1988 1999. QuickLogic’s fiscal year ends on the Sunday closest to December 31. 2020 2019 2018 January 3, 2021 December 29, 2019 December 30, 2018 COVID- 19 On January 30, 2020, 19 February 28, 2020, 19 19, As such, while COVID- 19 12 months ended January 3, 2021, 19 may 19. 19 19 may may 19 Restructuring In January 2020, January 24, 2020. twelve 2020, Liquidity The Company has financed its operations and capital investments through sale of common stock, capital and operating leases, a revolving line of credit and cash flows from operations. As of January 3, 2021 On September 28, 2018, On December 21, 2018, On November 6, 2019, one September 28, 2021. one one five one one On December 11, 2020, one September 28, 2022 one one The Company was in compliance with all loan covenants as of the end of the current reporting period. As of January 3, 2021, On June 21, 2019, 11 On June 22, 2020, 11 The Company currently uses its cash to fund its working capital, to accelerate the development of next generation products and for general corporate purposes. Based on past performance and current expectations, the Company believes that its existing cash and cash equivalents, together with available financial resources from the Revolving Facility with Heritage Bank will be sufficient to fund its operations and capital expenditures and provide adequate working capital for the next twelve Various factors affect the Company’s liquidity, including, among others: the level of revenue and gross profit as a result of the cyclicality of the semiconductor industry; the conversion of design opportunities into revenue; market acceptance of existing and new products including solutions based on its ArcticLink ® ® S3 Over the longer term, the Company anticipates that sales generated from its new product offerings, existing cash and cash equivalents, together with financial resources from its Revolving Facility with Heritage Bank, assuming renewal of the Revolving Facility or the Company entering into a new debt agreement with an alternative lender prior to the expiration of the revolving line of credit in September 2022, Principles of Consolidation The consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Principles, in the United States of America or US GAAP, and the applicable rules and regulations of the Securities and Exchange Commission, or SEC, and include the accounts of QuickLogic and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated. Foreign Currency The functional currency of the Company’s non-U.S. operations is the U.S. dollar. Accordingly, all monetary assets and liabilities of these foreign operations are translated into U.S. dollars at current period-end exchange rates and non-monetary assets and related elements of expense are translated using historical exchange rates. Income and expense elements are translated to U.S. dollars using the average exchange rates in effect during the period. Gains and losses from the foreign currency transactions of these subsidiaries are recorded as interest income and other expense, net in the statements of operations. Use of Estimates The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates, particularly in relation to revenue recognition; the allowance for doubtful accounts; sales returns; valuation of long-lived assets including mask sets; valuation of goodwill; capitalized internal-use software and related amortizable lives and intangibles related to the acquisition of SensiML, including the estimated useful lives of acquired intangible assets, valuation of inventories including identification of excess quantities, market value and obsolescence; measurement of stock-based compensation awards; accounting for income taxes and estimating accrued liabilities. Contracts with customers often include promises to transfer multiple products and services to a customer. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may Judgment is required to determine the Stand-alone Selling Price, or SSP, for each distinct performance obligation. The Company uses a range of amounts to estimate SSP when each of the products and services are sold separately and determines the discount to be allocated based on the relative SSP of the various products and services when products and services sold are bundled. In instances where SSP is not not may one may Concentration of Risk The Company’s accounts receivable are denominated in U.S. dollars and are derived primarily from sales to customers located in North America, Asia Pacific, and Europe. The Company performs ongoing credit evaluations of its customers and generally does not 14 Reverse Stock Split On November 26, 2019, 1 1 December 6, 2019. 1 $1.00 January 9, 2020, |
Note 2 - Significant Accounting
Note 2 - Significant Accounting Policies | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Significant Accounting Policies [Text Block] | NOTE 2 Cash Equivalents The Company considers all short-term, highly liquid investments with an original or a remaining maturity at purchase of ninety Fair Value The guidance for the fair value option for financial assets and financial liabilities provides companies the irrevocable option to measure many financial assets and liabilities at fair value with changes in fair value recognized in earnings or equity. The Company has not not Foreign Currency Transactions All of the Company’s sales and cost of manufacturing are transacted in U.S. dollars. The Company conducts a portion of its research and development activities in India and has sales and marketing activities in various countries outside of the United States. Most of these international expenses are incurred in local currency. Foreign currency transaction gains and losses, which are not 2020 2019 2018 2020 2019 2018 not Inventories Inventories are stated at the lower of standard cost or net realizable value. Standard cost approximates actual cost on a first first The Company’s semiconductor products have historically had an unusually long product life cycle and obsolescence has not Property and Equipment Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, generally one seven one seven Capitalized Internal-Use Software The Company capitalizes costs related to development of hosted services that the Company provides to its customers and internal use of enterprise-level business and finance software in support of the Company’s operational needs. Costs incurred in the application development phase are capitalized and amortized on a straight-line basis over their useful lives, which are generally five Long-Lived Assets The Company reviews the recoverability of its long-lived assets, such as property and equipment, annually and when events or changes in circumstances occur that indicate that the carrying value of the asset or asset group may not 2020 2019 2018 January 3, 2021 Licensed Intellectual Property The Company licenses intellectual property that is incorporated into its products. Costs incurred under license agreements prior to the establishment of technological feasibility are included in research and development expense as incurred. Costs incurred for intellectual property once technological feasibility has been established and that can be used in multiple products are capitalized as a long-term asset. Once a product incorporating licensed intellectual property has production sales, the amount is amortized over the estimated useful life of the asset, generally up to five Revenue Recognition The Company recognizes revenue in accordance with ASC Topic No. 606 Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company determines revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. As part of its assessment of each contract, the Company evaluates certain factors including the customer’s ability to pay, or credit risk. For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the price stated on the purchase order is typically fixed and represents the net consideration to which the Company expects to be entitled, and therefore there is no one not Product Revenue The Company generates most of its revenue by supplying standard hardware products, which must be programmed before they can be used in an application. The Company’s contracts with customers are generally for product only, and do not The Company recognizes hardware product revenue at the point of time when control of products is transferred to the customers, when the Company’s performance obligation is satisfied, which typically occurs upon shipment from the Company’s manufacturing site or its headquarters. Intellectual Property and Software License Revenue The Company also generates revenue from licensing their intellectual property or IP, software tools and royalty from licensing its technology. The Company recognizes IP and Software License revenue at the point of time when the control of IP or software license has been transferred. Some of the IP and Software Licensing contracts with customers contain multiple performance obligations. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. The Company determines the standalone selling prices based on our overall pricing objectives, taking into consideration market conditions and other factors, including the value of our contracts, type of the customer, customer tier, type of the technology used, customer demographics, geographic locations, and other factors. Software as a Service Revenue, or SaaS Revenue Software products that are offered to customers with a right to use the hosted software over the contract period without taking the possession of it are billed on a subscription basis. Revenue that are billed on a subscription basis is recognized ratably over the contract period. Maintenance Revenue The Company recognizes revenue from maintenance ratably over the term of the underlying maintenance contract term. Renewals of maintenance contracts create new performance obligations that are satisfied over the term with the revenues recognized ratably over the term. Royalty Revenue The Company recognizes royalty revenue when the later of the following events occurs: (a) The subsequent sale or usage occurs. (b) The performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied. Deferred Revenue Receivables are recognized in the period the Company ships the product. Payment terms on invoiced amounts are based on contractual terms with each customer. When the Company receives consideration, or such consideration is unconditionally due, prior to transferring goods or services to the customer under the terms of a sales contract, the Company records deferred revenue, which represents a contract liability. The Company recognizes deferred revenue as net sales once control of goods and/or services have been transferred to the customer and all revenue recognition criteria have been met and any constraints have been resolved. The Company defers the product costs until recognition of the related revenue occurs. Assets Recognized from Costs to Obtain a Contract with a Customer The Company recognizes an asset for the incremental costs of obtaining a contract with a customer, if it expects the benefit of those costs to be longer than one none 606 no January 3, 2021 Practical expedients and exemptions (i) Taxes collected from customers and remitted to government authorities and that are related to the sales of the Company’s products are excluded from revenues. (ii) Sales commissions are expensed when incurred because the amortization period would have been one (iii) The Company does not one The Company records allowance for sales returns. Amounts recorded for sales returns for the year ended January 3, 2021 December 29, 2019 The Company accounts for its Intellectual Property or IP license revenues and related services in accordance with Financial Accounting Standard Board or FASB Accounting Standards Codification or ASC No. 985 605, Software Revenue Recognition no may not one third not Cost of Revenue The Company records all costs associated with its product sales in cost of revenue. These costs include the cost of materials, contract manufacturing fees, shipping costs and quality assurance. Cost of revenue also includes indirect costs such as warranty, excess and obsolete inventory charges, general overhead costs and depreciation. Accounts Receivable Allowance The Company estimates the amount of uncollectible accounts receivable at the end of each reporting period based on the aging of the receivable balance, current and historical customer trends, and communications with its customers. Amounts are written off only after considerable collection efforts have been made and the amounts are determined to be uncollectible. Warranty Costs The Company warrants finished goods against defects in material and workmanship under normal use for twelve not 606. not not Leases The Company adopted ASU No. 2016 02, Leases (Topic 842 December 31, 2018, no not . Under Topic 842, not 12 ROU assets represent the Company’s right to use an underlying asset during the reasonably certain lease terms and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company’s lease terms may In accordance with ASU No. 2016 02, March 31, 2019, no 2020, January 3, 2021 8 Business Combinations The Company recognizes assets acquired (including goodwill and identifiable intangible assets) and liabilities assumed at fair value on the acquisition date. Subsequent changes to the fair value of such assets acquired and liabilities assumed are recognized in earnings, after the expiration of the measurement period, a period not 12 Goodwill and Intangible Assets Goodwill represents the excess fair value of consideration transferred over the fair value of net assets acquired in business combinations. The carrying value of goodwill and indefinite lived intangible assets are not 2019 12 Intangible assets with finite useful lives are amortized on a straight-line basis over the periods benefited. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset or asset group may not No Restricted cash Restricted cash represents amounts pledged as cash security related to the Company’s credit cards. Advertising Costs related to advertising and promotion expenditures are charged to “Selling, general and administrative” expense in the consolidated statements of operations as incurred. Costs related to advertising and promotion expenditures were $76,000 in 2020 2019 2018 Stock-Based Compensation The Company accounts for stock-based compensation under the provisions of the amended authoritative guidance, and related interpretations which require the measurement and recognition of expense related to the fair value of stock-based compensation awards. The fair value of stock-based compensation awards is measured at the grant date and re-measured upon modification, as appropriate. The Company uses the Black-Scholes option pricing model to estimate the fair value of employee stock options and rights to purchase shares under the Company’s 1999 13 Accounting for Income Taxes The Company is required to estimate its income taxes in each of the jurisdictions in which the Company operates. This process involves estimating the Company’s actual current tax exposure together with assessing temporary differences resulting from different tax and accounting treatment of items, such as deferred revenue, allowance for doubtful accounts, the impact of equity awards, depreciation and amortization and employee related accruals. These differences result in deferred tax assets and liabilities, which are included on the Company’s balance sheets. The Company must then assess the likelihood that its deferred tax assets will be recovered from future taxable income and to the extent the Company believes that recovery is not Significant management judgment is required in determining the Company’s provision for income taxes, the Company’s deferred tax assets and liabilities and any valuation allowance recorded against the Company's net deferred tax assets. The Company’s deferred tax assets, consisting primarily of net operating loss carryforwards, amounted to $61 million tax effected as of the end of 2020 2020 The Company accounts for uncertainty in income taxes using a two first not second 50% one Concentrations of Credit and Suppliers Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents and accounts receivable. Cash and cash equivalents are maintained with high quality institutions. The Company’s accounts receivables are denominated in U.S. dollars and are derived primarily from sales to customers located in North America, Europe and Asia Pacific. The Company performs ongoing credit evaluations of its customers and generally does not 14 The Company depends on a limited number of contract manufacturers, subcontractors, and suppliers for wafer fabrication, assembly, programming and test of its devices, and for the supply of programming equipment, and these services are typically provided by one Comprehensive Income (Loss) Comprehensive income (loss) includes all temporary changes in equity (net assets) during a period from non-owner sources. The Company’s comprehensive loss equaled to net loss for all periods presented. Recently Adopted New Accounting Pronouncements: In August 2018, No. 2018 13, Fair Value Measurement (Topic 820 January 1, 2020. December 30, 2019 no In August 2018, No. 2018 15, Intangibles - Goodwill and Other Internal-Use Software (Subtopic 350 40 Customer s Accounting for Implementations Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. December 15, 2019, December 30, 2019 no In June 2016, No. 2016 13 2016 13” Financial Instruments-Credit Losses (Topic 326 Measurement of Credit Losses on Financial Instruments 2016 13 2016 13 December 30, 2019 no New Accounting Pronouncements In December 2019, No. 2019 12, Simplifying the Accounting for Income Taxes 740, 1 2 3 December 15, 2020. 2019 12, January 4, 2021, not In August 2020, No. 2020 06, Debt—Debt with Conversion and Other Options (Subtopic 470 20 815 40 December 15, 2021, not No. 2020 06 |
Note 3 - Net Loss Per Share
Note 3 - Net Loss Per Share | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Earnings Per Share [Text Block] | NOTE 3 Basic net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net loss per share was computed using the weighted average number of common shares outstanding during the period plus potentially dilutive common shares outstanding during the period under the treasury stock method. In computing diluted net loss per share, the weighted average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options and warrants. For 2020 2019 2018 2009 not May 29, 2018 not January 3, 2021 December 29, 2019 On December 6, 2019, 1 December 23, 2019. November 26, 2019. |
Note 4 - Balance Sheet Componen
Note 4 - Balance Sheet Components | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Supplemental Balance Sheet Disclosures [Text Block] | NOTE 4 January 3, December 29, 2021 2019 (in thousands) Inventories: Raw material $ 191 $ 222 Work-in-process 1,842 2,370 Finished goods 655 668 $ 2,688 $ 3,260 Other current assets: Prepaid expenses $ 884 $ 1,296 Other 182 269 $ 1,066 $ 1,565 Property and equipment: Equipment $ 10,471 $ 10,694 Software 1,783 1,789 Furniture and fixtures 33 36 Leasehold improvements 466 474 12,753 12,993 Accumulated depreciation and amortization (12,205 ) (12,163 ) $ 548 $ 830 Capitalized internal-use software: Capitalized software held for internal use $ 1,166 $ 365 Accumulated amortization (180 ) (32 ) $ 986 $ 333 Accrued liabilities: Employee compensation related accruals 762 713 Other 578 420 $ 1,340 $ 1,133 The Company recorded depreciation and amortization expense of $817,000, $1.2 million and $1.3 million for the fiscal years 2020 2019 2018 2020 2019 |
Note 5 - Business Acquisition
Note 5 - Business Acquisition | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Business Combination Disclosure [Text Block] | NOTE 5 SensiML Acquisition On January 3, 2019, SensiML has a software toolkit enabling IoT developers to quickly and easily create smart devices, transforming rich sensors into actionable event detectors. SensiML’s Analytics Toolkit is an end-to-end software suite that provides OEMs a straightforward process for developing pattern matching sensor algorithms using machine learning technology that are optimized for ultra-low power consumption. The SensiML Analytics Toolkit enables OEMs to quickly and easily leverage the power of local AI in edge, endpoint and wearable designs without the need for significant Data Science or Firmware Engineering resources. The results of operations for the Company for the fiscal year ended January 3, 2021 January 3, 2019. January 3, 2021 December 29, 2019 January 3, 2021 December 29, 2019 2019. Purchase Price Allocation Under the purchase accounting method, the total purchase price was allocated to SensiML’s net tangible and intangible assets based upon their estimated fair values as of the acquisition date. The excess purchase price over the value of the net tangible and identified intangible assets was recorded as goodwill. During the measurement period, which can be no one 2019 Intangible assets associated with the acquisition is primarily attributable to the future technology, market presence and knowledgeable and experienced workforce. The fair value assigned to identifiable intangible assets acquired was determined using the income approach taking into account the Company’s consideration of a number of inputs, including an independent third not not The Stock Purchase Agreement contains customary representations and warranties between the Company and SensiML, who agreed to indemnify each other for certain breaches of representations, warranties, covenants and other specified matters. Approximately $200,000 in value of the Company’s common stock of the purchase price was placed in escrow as security for post-closing working capital adjustments, which expired on January 2, 2020. |
Note 6 - Intangible Assets
Note 6 - Intangible Assets | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Intangible Assets Disclosure [Text Block] | NOTE 6 The following table provides the details of the carrying value of intangible assets recorded from the acquisition of SensiML as of January 3, 2021 January 3, 2021 Useful Life Gross Carrying Amount Accumulated Amortization Net Carrying Amount Developed technology 10 $ 959 $ (192 ) $ 767 Customer relationships 2 81 (81 ) — Trade names and trade marks 10 116 (23 ) 93 Total acquired identifiable intangible assets $ 1,156 $ (296 ) $ 860 The following table provides the details of the carrying value of intangible assets recorded from the acquisition of SensiML as of December 29, 2019 December 29, 2019 Useful Life Gross Carrying Amount Accumulated Amortization Net Carrying Amount Developed technology 10 $ 959 $ (96 ) $ 863 Customer relationships 2 81 (40 ) 41 Trade names and trade marks 10 116 (12 ) 104 Total acquired identifiable intangible assets $ 1,156 $ (148 ) $ 1,008 The following table provides the details of future annual amortization of intangible assets, based upon the current useful lives as of January 3, 2021 Amount Annual Fiscal Years 2021 107 2022 107 2023 107 2024 107 2025 107 Thereafter 325 Total $ 860 |
Note 7 - Debt Obligations
Note 7 - Debt Obligations | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Debt and Capital Leases Disclosures [Text Block] | NOTE 7 Revolving Line of Credit On September 28, 2018, On December 21, 2018, $9.0 On November 6, 2019 one September 28, 2021. one one five one one On December 11, 2020, one September 28, 2022 one one As of January 3, 2021 December 29, 2019 The Bank has a first Payroll Protection Program Loan On May 6, 2020, The PPP Loan is evidenced by a promissory note (“Note”) dated May 6, 2020, two first six six may no may fourth 2020, January 26, 2021, 16, |
Note 8 - Leases
Note 8 - Leases | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Lessee, Operating and Finance Leases [Text Block] | NOTE 8 The Company entered into operating leases for office space for its headquarters, domestic and foreign subsidiaries and sales offices. Finance leases are primarily for engineering design software. Operating leases generally have lease terms of 1 year to 5 years. Finance leases are generally 2 years to 3 years. For the year ended January 3, 2021 December 29, 2019 In October 2018, July 2020. not On February 13, 2019, 2220 95131 five April 15, 2019 In April 2019, March 2021. The Company leases a 9,400 square foot facility in Bangalore, India for the purpose of software development, which is leased through June 2021. July 10, 2020, 2020 9,400 December 2020 January 3, 2021 In addition, the Company rents sales offices in Europe and Asia. Total rent expense during 2020 2019 2018 The following table provides the activity related to operating and finance leases (in thousands): Fiscal Year Ended Fiscal Year Ended January 3, 2021 December 29, 2019 Operating lease costs: Fixed $ 473 $ 757 Variable — — Short term 20 40 Total 493 797 Finance lease costs: Amortization of ROU asset 315 388 Interest 38 18 Total $ 353 $ 406 The following table provides the details of supplemental cash flow information (in thousands): Fiscal Year Ended Fiscal Year Ended January 3, 2021 December 29, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used for operating leases $ 497 $ 791 Operating cash flows used for finance leases 38 24 Financing cash flows used for financing leases 270 365 Total $ 805 $ 1,180 Right-of-use assets obtained in exchange for obligations: Operating leases $ — $ 2,200 Finance leases 914 170 Total $ 914 $ 2,370 The following table provides the details of right-of-use assets and lease liabilities as of January 3, 2021 January 3, 2021 December 29, 2019 Right-of-use assets: Operating leases $ 1,134 $ 2,200 Finance leases 705 170 Total $ 1,839 $ 2,370 Lease liabilities: Operating leases 1,212 1,816 Finance leases 670 471 Total $ 1,882 $ 2,287 The following table provides the details of future lease payments for operating and finance leases as of January 3, 2021 Annual Fiscal Years Operating Finance 2021 $ 402 $ 375 2022 409 335 2023 422 — 2024 106 — Total lease payments 1,339 710 Less: Interest (127 ) (40 ) Present value of lease liabilities $ 1,212 $ 670 The following table provides the details of lease terms and discount rates as of January 3, 2021 January 3, 2021 Right-of-use assets: Weighted-average remaining lease term (years) Operating leases 3.24 Finance leases 2.21 Weighted-average discount rates: Operating leases 6.00 % Finance leases 5.50 % |
Note 9 - Fair Value Measurement
Note 9 - Fair Value Measurements | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Fair Value Disclosures [Text Block] | NOTE 9 Pursuant to the accounting guidance for fair value measurements and its subsequent updates, fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market and it considers assumptions that market participants would use when pricing the asset or liability. The accounting guidance for fair value measurement also specifies a hierarchy of valuation techniques based upon whether the inputs to those valuation techniques reflect assumptions other market participants would use based upon market data obtained from independent sources (observable inputs) or reflect the Company’s own assumption of market participant valuation (unobservable inputs). The fair value hierarchy consists of the following three • Level 1 • Level 2 not • Level 3 one Our cash and cash equivalents include money market account balances of $22.0 million and $20.9 million as of January 3, 2021 December 29, 2019 1 |
Note 10 - Income Taxes
Note 10 - Income Taxes | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Income Tax Disclosure [Text Block] | NOTE 10 The following table presents the U.S. and foreign components of consolidated loss before income taxes and the provision for (benefit from) income taxes (in thousands): Fiscal Years 2020 2019 2018 Loss before income taxes: U.S. $ (11,170 ) $ (15,813 ) $ (13,982 ) Foreign 70 289 355 Loss before income taxes $ (11,100 ) $ (15,524 ) $ (13,627 ) Provision for (benefit from) income taxes: Current: Federal $ — $ — $ (19 ) State 3 3 2 Foreign 39 108 169 Subtotal 42 111 152 Deferred: Federal — (141 ) — State — (44 ) — Foreign 9 (6 ) — Subtotal 9 (191 ) — Provision for (benefit from) income taxes $ 51 $ (80 ) $ 152 The following table presents the rate reconciliation between income tax provisions at the U.S. federal statutory rate and the effective rate reflected in the consolidated statements of operations: Fiscal Years 2020 2019 2018 Income tax (benefit) at statutory rate $ (2,331 ) $ (3,260 ) $ (2,862 ) State taxes 3 (42 ) 2 Stock compensation and other permanent differences 99 187 252 Foreign taxes 34 42 95 Future benefit of deferred tax assets not recognized 2,246 3,133 2,684 Other — (140 ) (19 ) Provision for (benefit from) income taxes $ 51 $ (80 ) $ 152 Based on the available objective evidence, management believes it is more likely than not not January 3, 2021 may not January 3, December 29, 2021 2019 Deferred tax assets: Net operating losses $ 43,703 $ 40,717 Accruals and reserves 1,239 1,345 Credits carryforward 5,860 5,765 Depreciation and amortization 9,240 9,760 Stock-based compensation 485 637 Operating lease liability 469 529 Gross deferred tax assets 60,996 58,753 Deferred tax liabilities: Right-of-use asset (458 ) (552 ) Gross deferred tax assets (458 ) (552 ) Net deferred tax assets 60,538 58,201 Valuation allowance (60,486 ) (58,140 ) Total deferred tax asset $ 52 $ 61 As of January 3, 2021 not January 1, 2018 2021 2038, January 1, 2018 not 2021 2040. The Company has research credit carryforwards of approximately $4.1 million for federal and $4.6 million for state income tax purposes as of January 3, 2021 not 2021. The Tax Cuts and Jobs Act (the "TCJA") was enacted on December 22, 2017. one December 2017, No. 118 118” 118 not one 740, 740” 118, no 2018 fourth Events which may not 382 may The Company has not may Foreign withholding taxes associated with the repatriation of earnings of foreign subsidiaries were not 2020 not not Uncertain Tax Positions A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands): January 3, December 29, December 30, 2021 2019 2018 Beginning balance of unrecognized tax benefits $ 2,117 $ 2,161 $ 2,107 Additions (subtractions) for tax positions related to the prior year 38 (46 ) (2 ) Additions for tax positions related to the current year 114 88 125 Lapse of statutes of limitations (93 ) (86 ) (69 ) Ending balance of unrecognized tax benefits $ 2,176 $ 2,117 $ 2,161 Out of $2.2 million of unrecognized tax benefits, there are no unrecognized tax benefits that would result in a change in the Company's effective tax rate if recognized in future years. The accrued interest and penalties related to uncertain tax positions was not January 3, 2021 December 29, 2019 December 30, 2018 On March 27, 2020, The Company is not may not twelve The Company is subject to U.S. federal income tax as well as income taxes in many U.S. states and foreign jurisdictions in which the Company operates. The U.S. tax years from 1999 |
Note 11 - Stockholders' Equity
Note 11 - Stockholders' Equity | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Stockholders' Equity Note Disclosure [Text Block] | NOTE 11 Common and Preferred Stock As of January 3, 2021 Reverse Stock Split On December 6, 2019, 1 December 23, 2019. November 26, 2019. 14 one 10 May 2018 Issuance of Common Stock On June 22, 2020, 30 July 21, 2020 On June 21, 2019, third 2019. On March 15, 2019, 3, may, one March 29, 2019. In May 2018, one The warrants are exercisable any time for a period of 60 months from the date of issuance on May 29, 2018, zero As of January 3, 2021, |
Note 12 - Employee Stock Plans
Note 12 - Employee Stock Plans | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Disclosure of Employee Stock Ownership Plans [Text Block] | NOTE 12 2009 The 2009 2009 January 2015, February 2017, March 15, 2018 April 23, 2015, April 26, 2017 April 25, 2018 2009 April 24, 2019, 2009 2019 ten March 15, 2028. 2009 April 24, 2019. 2019 On April 24, 2019, 2019 2019 2009 2009 2019 2009 January 3, 2021 2019 Options typically vest at a rate of 25% one one forty eighth one one eighth six may Employee Stock Purchase Plan The 2009 2009 March 2009. 2009 January 2015 February 2017, April 23, 2015 April 26, 2017, 2009 On May 6, 2019, 2009 March 5, 2029, 12 2009 As of January 3, 2021 2009 2009 six 2009 85% 85% |
Note 13 - Stock-based Compensat
Note 13 - Stock-based Compensation | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Share-based Payment Arrangement [Text Block] | NOTE 13 The Company provides stock-based incentive compensation, or awards, to eligible employees and non-employee directors. Awards that may four ten Stock-based compensation expense is recognized in the Company’s consolidated statements of operations and includes compensation expense for the stock-based compensation awards granted or modified subsequent to January 1, 2006, 2020 2019 2018 Fiscal Years 2020 2019 2018 Cost of revenue $ 162 $ 78 $ 129 Research and development 670 2,242 760 Selling, general and administrative 907 824 1,012 Total costs and expenses $ 1,739 $ 3,144 $ 1,901 No stock-based compensation was capitalized or included in inventories at the end of 2020 2019 2018 Stock-Based Compensation Award Activity The following table summarizes the shares available for grant under the 2019 Shares Available for Grant Balance at December 29, 2019 272 Authorized 550 Options granted — Options forfeited or expired 65 RSUs granted (816 ) RSUs forfeited 249 Balance at January 3, 2021 320 Stock Options The following table summarizes stock options outstanding and stock option activity under the 2019 2020 2019 2018 Number of Shares Weighted Average Exercise Price Weighted Average Remaining Term Aggregate Intrinsic Value (in thousands) (in years) (in thousands) Balance outstanding at December 31, 2017 254 $ 29.26 4.34 Granted — — Forfeited or expired (10 ) 25.20 Exercised (15 ) 12.60 Balance outstanding at December 30, 2018 229 30.52 3.70 Granted — — Forfeited or expired (42 ) 24.14 Exercised (1 ) 10.92 Balance outstanding at December 29, 2019 186 32.09 3.32 Granted — — Forfeited or expired (65 ) 38.83 Exercised — — Balance outstanding at January 3, 2021 121 $ 28.46 3.75 $ — Exercisable and Vested and expected to vest at January 3, 2021 121 $ 28.46 3.75 $ — There was no intrinsic value for the stock options, based on the Company’s closing stock price of $3.79 per share as of the end of the Company’s current reporting period, which would have been received by the option holders had all option holders exercised their options as of that date. The total intrinsic value of options exercised during 2020 2019 2018 not 2020 2019 2018 no Total stock-based compensation expense recognized related to stock options was $39,000, $117,000, and $131,000 for 2020 2019 2018 No 2020 2019 2018 2020 Significant exercise price ranges of options outstanding, related weighted average exercise prices and contractual life information at the end of 2020 Options Outstanding Options Exercisable Range of Exercise Prices Options Outstanding Weighted Average Remaining Contractual Life Weighted Average Exercise Price Options Vested and Exercisable Weighted Average Exercise Price (in thousands) (in years) (in thousands) $12.05 52 5.68 $ 12.05 52 $ 12.05 $18.48 - $31.50 14 2.82 26.71 14 26.71 $32.20 3 2.34 32.2 3 32.20 $38.92 14 0.85 38.92 14 38.92 $39.48 - $44.94 9 2.76 42.94 9 42.91 $46.62 3 3.34 46.62 3 46.62 $47.46 14 2.94 47.46 14 47.46 $48.72 8 1.35 48.72 8 48.72 $53.48 4 3.38 53.48 4 53.48 $12.05- $53.48 121 3.75 $ 28.46 121 $ 28.46 Valuation Assumptions The Company uses the Black-Scholes option pricing model to estimate the fair value of employee stock options and rights to purchase shares under the Company’s 2009 In addition to the assumptions used in the Black-Scholes pricing model, the amended authoritative guidance requires that the Company recognize expense for awards ultimately expected to vest; therefore, the Company is required to develop an estimate of the number of awards expected to be forfeited prior to vesting, or forfeiture rate. The forfeiture rate is estimated based on historical pre-vest cancellation experience and is applied to all share-based awards. No stock options were granted during the years 2020 2019 2018 Restricted Stock Units The Company grants restricted stock units, or RSUs, to employees with various vesting terms. RSUs entitle the holder to receive, at no one 2020 2019 2018 The following table summarizes RSU’s activity under the 2019 2020 2019 2018 RSUs & PRSUs Outstanding Number of Shares Weighted Average Grant Date Fair Value (in thousands) Nonvested at December 31, 2017 168 $ 21.56 Granted 110 11.90 Vested (77 ) 19.18 Forfeited (18 ) — Nonvested at December 30, 2018 183 17.22 Granted 353 10.77 Vested (118 ) 14.48 Forfeited (41 ) — Nonvested at December 29, 2019 377 $ 12.55 Granted 816 3.97 Vested (144 ) 10.41 Forfeited (249 ) 7.93 Nonvested at January 3, 2021 800 $ 4.99 Employee Stock Purchase Plan The weighted average estimated fair value, as defined by the amended authoritative guidance, of rights issued pursuant to the Company’s ESPP during 2020 2019 2018 2020 2019 2018 As of January 3, 2021 2009 2020 2019 2018 The fair value of rights issued pursuant to the Company’s ESPP was estimated on the commencement date of each offering period using the following weighted average assumptions: Fiscal Years 2020 2019 2018 Expected life (months) 6.0 6.0 6.0 Risk-free interest rate 0.12 % 2.37 % 2.26 % Volatility 82 % 54 % 50 % Dividend yield — — — The methodologies for determining the above values were as follows: • Expected term: The expected term represents the length of the purchase period contained in the ESPP. • Risk-free interest rate: The risk-free interest rate assumption is based upon the risk-free rate of a Treasury Constant Maturity bond with a maturity appropriate for the term of the purchase period. • Volatility: The Company determines expected volatility based on historical volatility of the Company’s common stock for the term of the purchase period. • Dividend Yield: The expected dividend assumption is based on the Company’s intent not |
Note 14 - Information Concernin
Note 14 - Information Concerning Product Lines, Geographic Information, Accounts Receivable and Revenue Concentration | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Segment Reporting Disclosure [Text Block] | NOTE 14 The Company identifies its business segments based on business activities, management responsibility and geographic location. For all periods presented, the Company operated in a single reportable business segment. The following is a breakdown of revenue by product family (in thousands): Fiscal Years 2020 2019 2018 Revenue by product line (1) : New products $ 2,782 $ 3,123 $ 5,735 Mature products 5,852 7,187 6,894 Total revenue $ 8,634 $ 10,310 $ 12,629 ( 1 New products include all products manufactured on 180 180 The following is a breakdown of revenue by shipment destination (in thousands): Fiscal Years 2020 2019 2018 Revenue by geography: Asia Pacific (1) $ 2,096 $ 3,049 $ 4,905 Europe 1,501 2,459 1,280 North America (2) 5,037 4,802 6,444 Total revenue $ 8,634 $ 10,310 $ 12,629 ( 1 Asia Pacific includes revenue from Japan of $2.0 million or 23% of total revenue in 2020 2019 2018 ( 2 North America includes revenue from the United States of $5.0 million or 58% of total revenue in 2020 2019 2018 The following distributors and customers accounted for 10% Fiscal Years 2020 2019 2018 Distributor "A" 24 % 40 % 34 % Distributor "C" 15 % 13 % * Distributor "E" 19 % * * Customer "B" 10 % 13 % 12 % Customer "E" * 10 % * Customer "F" 19 % * * Customer "G" * * 10 % Customer "J" * * 10 % Customer "M" 16 % * * Note: the amounts related to Distributor in the above table represent sales-in only to those distributors, and Customer information relates to sales out information. As such, sales to a Distributor, may The following distributors and customers accounted for 10% January 3, December 29, 2021 2019 Distributor "A" * 20 % Distributor "C" * 23 % Distributor "E" * 12 % Distributor "J" * 31 % Customer "P" 67 % * Customer "Q" 10 % * As of January 3, 2021 December 29, 2019 |
Note 15 - Commitments and Conti
Note 15 - Commitments and Contingencies | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Commitments Disclosure [Text Block] | NOTE 15 Commitments Certain wafer manufacturers require the Company to forecast wafer starts several months in advance. The Company is committed to take delivery of and pay for a portion of forecasted wafer volume. As of the end of 2020 2019 The Company has purchase obligations with certain suppliers for the purchase of goods and services entered into in the ordinary course of business. As of January 3, 2021 twelve Litigation From time to time, the Company may not third not may |
Note 16 - Subsequent Events
Note 16 - Subsequent Events | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | NOTE 16 Payroll Protection Program Loan On May 6, 2020, The Company applied for loan forgiveness in the fourth 2020, January 26, 2021, first April 4, 2021. India Transfer Pricing notice On January 27, 2021, 2017 18, may not may |
Schedule II - Valuation and Qua
Schedule II - Valuation and Qualifying Accounts | 12 Months Ended |
Jan. 03, 2021 | |
Notes to Financial Statements | |
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] | QuickLogic Corporation Valuation and Qualifying Accounts (in thousands) Allowance for Deferred Tax Assets: Fiscal Year 2020 $ 58,140 $ 2,398 $ — $ 60,538 Fiscal Year 2019 $ 54,913 $ 3,227 $ — $ 58,140 Fiscal Year 2018 $ 55,931 $ — $ (1,018 ) $ 54,913 |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 12 Months Ended |
Jan. 03, 2021 | |
Accounting Policies [Abstract] | |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash Equivalents The Company considers all short-term, highly liquid investments with an original or a remaining maturity at purchase of ninety |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value The guidance for the fair value option for financial assets and financial liabilities provides companies the irrevocable option to measure many financial assets and liabilities at fair value with changes in fair value recognized in earnings or equity. The Company has not not |
Foreign Currency Transactions and Translations Policy [Policy Text Block] | Foreign Currency Transactions All of the Company’s sales and cost of manufacturing are transacted in U.S. dollars. The Company conducts a portion of its research and development activities in India and has sales and marketing activities in various countries outside of the United States. Most of these international expenses are incurred in local currency. Foreign currency transaction gains and losses, which are not 2020 2019 2018 2020 2019 2018 not |
Inventory, Policy [Policy Text Block] | Inventories Inventories are stated at the lower of standard cost or net realizable value. Standard cost approximates actual cost on a first first The Company’s semiconductor products have historically had an unusually long product life cycle and obsolescence has not |
Property, Plant and Equipment, Policy [Policy Text Block] | Property and Equipment Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, generally one seven one seven Capitalized Internal-Use Software The Company capitalizes costs related to development of hosted services that the Company provides to its customers and internal use of enterprise-level business and finance software in support of the Company’s operational needs. Costs incurred in the application development phase are capitalized and amortized on a straight-line basis over their useful lives, which are generally five Long-Lived Assets The Company reviews the recoverability of its long-lived assets, such as property and equipment, annually and when events or changes in circumstances occur that indicate that the carrying value of the asset or asset group may not 2020 2019 2018 January 3, 2021 |
Intangible Assets, Finite-Lived, Policy [Policy Text Block] | Licensed Intellectual Property The Company licenses intellectual property that is incorporated into its products. Costs incurred under license agreements prior to the establishment of technological feasibility are included in research and development expense as incurred. Costs incurred for intellectual property once technological feasibility has been established and that can be used in multiple products are capitalized as a long-term asset. Once a product incorporating licensed intellectual property has production sales, the amount is amortized over the estimated useful life of the asset, generally up to five |
Revenue from Contract with Customer [Policy Text Block] | Revenue Recognition The Company recognizes revenue in accordance with ASC Topic No. 606 Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company determines revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. As part of its assessment of each contract, the Company evaluates certain factors including the customer’s ability to pay, or credit risk. For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the price stated on the purchase order is typically fixed and represents the net consideration to which the Company expects to be entitled, and therefore there is no one not Product Revenue The Company generates most of its revenue by supplying standard hardware products, which must be programmed before they can be used in an application. The Company’s contracts with customers are generally for product only, and do not The Company recognizes hardware product revenue at the point of time when control of products is transferred to the customers, when the Company’s performance obligation is satisfied, which typically occurs upon shipment from the Company’s manufacturing site or its headquarters. Intellectual Property and Software License Revenue The Company also generates revenue from licensing their intellectual property or IP, software tools and royalty from licensing its technology. The Company recognizes IP and Software License revenue at the point of time when the control of IP or software license has been transferred. Some of the IP and Software Licensing contracts with customers contain multiple performance obligations. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. The Company determines the standalone selling prices based on our overall pricing objectives, taking into consideration market conditions and other factors, including the value of our contracts, type of the customer, customer tier, type of the technology used, customer demographics, geographic locations, and other factors. Software as a Service Revenue, or SaaS Revenue Software products that are offered to customers with a right to use the hosted software over the contract period without taking the possession of it are billed on a subscription basis. Revenue that are billed on a subscription basis is recognized ratably over the contract period. Maintenance Revenue The Company recognizes revenue from maintenance ratably over the term of the underlying maintenance contract term. Renewals of maintenance contracts create new performance obligations that are satisfied over the term with the revenues recognized ratably over the term. Royalty Revenue The Company recognizes royalty revenue when the later of the following events occurs: (a) The subsequent sale or usage occurs. (b) The performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied. Deferred Revenue Receivables are recognized in the period the Company ships the product. Payment terms on invoiced amounts are based on contractual terms with each customer. When the Company receives consideration, or such consideration is unconditionally due, prior to transferring goods or services to the customer under the terms of a sales contract, the Company records deferred revenue, which represents a contract liability. The Company recognizes deferred revenue as net sales once control of goods and/or services have been transferred to the customer and all revenue recognition criteria have been met and any constraints have been resolved. The Company defers the product costs until recognition of the related revenue occurs. Assets Recognized from Costs to Obtain a Contract with a Customer The Company recognizes an asset for the incremental costs of obtaining a contract with a customer, if it expects the benefit of those costs to be longer than one none 606 no January 3, 2021 Practical expedients and exemptions (i) Taxes collected from customers and remitted to government authorities and that are related to the sales of the Company’s products are excluded from revenues. (ii) Sales commissions are expensed when incurred because the amortization period would have been one (iii) The Company does not one The Company records allowance for sales returns. Amounts recorded for sales returns for the year ended January 3, 2021 December 29, 2019 The Company accounts for its Intellectual Property or IP license revenues and related services in accordance with Financial Accounting Standard Board or FASB Accounting Standards Codification or ASC No. 985 605, Software Revenue Recognition no may not one third not Cost of Revenue The Company records all costs associated with its product sales in cost of revenue. These costs include the cost of materials, contract manufacturing fees, shipping costs and quality assurance. Cost of revenue also includes indirect costs such as warranty, excess and obsolete inventory charges, general overhead costs and depreciation. |
Accounts Receivable [Policy Text Block] | Accounts Receivable Allowance The Company estimates the amount of uncollectible accounts receivable at the end of each reporting period based on the aging of the receivable balance, current and historical customer trends, and communications with its customers. Amounts are written off only after considerable collection efforts have been made and the amounts are determined to be uncollectible. |
Standard Product Warranty, Policy [Policy Text Block] | Warranty Costs The Company warrants finished goods against defects in material and workmanship under normal use for twelve not 606. not not |
Lessee, Leases [Policy Text Block] | Leases The Company adopted ASU No. 2016 02, Leases (Topic 842 December 31, 2018, no not . Under Topic 842, not 12 ROU assets represent the Company’s right to use an underlying asset during the reasonably certain lease terms and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company’s lease terms may In accordance with ASU No. 2016 02, March 31, 2019, no 2020, January 3, 2021 8 |
Business Combinations Policy [Policy Text Block] | Business Combinations The Company recognizes assets acquired (including goodwill and identifiable intangible assets) and liabilities assumed at fair value on the acquisition date. Subsequent changes to the fair value of such assets acquired and liabilities assumed are recognized in earnings, after the expiration of the measurement period, a period not 12 |
Goodwill and Intangible Assets, Policy [Policy Text Block] | Goodwill and Intangible Assets Goodwill represents the excess fair value of consideration transferred over the fair value of net assets acquired in business combinations. The carrying value of goodwill and indefinite lived intangible assets are not 2019 12 Intangible assets with finite useful lives are amortized on a straight-line basis over the periods benefited. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset or asset group may not No |
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] | Restricted cash Restricted cash represents amounts pledged as cash security related to the Company’s credit cards. |
Advertising Cost [Policy Text Block] | Advertising Costs related to advertising and promotion expenditures are charged to “Selling, general and administrative” expense in the consolidated statements of operations as incurred. Costs related to advertising and promotion expenditures were $76,000 in 2020 2019 2018 |
Share-based Payment Arrangement [Policy Text Block] | Stock-Based Compensation The Company accounts for stock-based compensation under the provisions of the amended authoritative guidance, and related interpretations which require the measurement and recognition of expense related to the fair value of stock-based compensation awards. The fair value of stock-based compensation awards is measured at the grant date and re-measured upon modification, as appropriate. The Company uses the Black-Scholes option pricing model to estimate the fair value of employee stock options and rights to purchase shares under the Company’s 1999 13 |
Income Tax, Policy [Policy Text Block] | Accounting for Income Taxes The Company is required to estimate its income taxes in each of the jurisdictions in which the Company operates. This process involves estimating the Company’s actual current tax exposure together with assessing temporary differences resulting from different tax and accounting treatment of items, such as deferred revenue, allowance for doubtful accounts, the impact of equity awards, depreciation and amortization and employee related accruals. These differences result in deferred tax assets and liabilities, which are included on the Company’s balance sheets. The Company must then assess the likelihood that its deferred tax assets will be recovered from future taxable income and to the extent the Company believes that recovery is not Significant management judgment is required in determining the Company’s provision for income taxes, the Company’s deferred tax assets and liabilities and any valuation allowance recorded against the Company's net deferred tax assets. The Company’s deferred tax assets, consisting primarily of net operating loss carryforwards, amounted to $61 million tax effected as of the end of 2020 2020 The Company accounts for uncertainty in income taxes using a two first not second 50% one |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentrations of Credit and Suppliers Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents and accounts receivable. Cash and cash equivalents are maintained with high quality institutions. The Company’s accounts receivables are denominated in U.S. dollars and are derived primarily from sales to customers located in North America, Europe and Asia Pacific. The Company performs ongoing credit evaluations of its customers and generally does not 14 The Company depends on a limited number of contract manufacturers, subcontractors, and suppliers for wafer fabrication, assembly, programming and test of its devices, and for the supply of programming equipment, and these services are typically provided by one |
Comprehensive Income, Policy [Policy Text Block] | Comprehensive Income (Loss) Comprehensive income (loss) includes all temporary changes in equity (net assets) during a period from non-owner sources. The Company’s comprehensive loss equaled to net loss for all periods presented. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently Adopted New Accounting Pronouncements: In August 2018, No. 2018 13, Fair Value Measurement (Topic 820 January 1, 2020. December 30, 2019 no In August 2018, No. 2018 15, Intangibles - Goodwill and Other Internal-Use Software (Subtopic 350 40 Customer s Accounting for Implementations Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. December 15, 2019, December 30, 2019 no In June 2016, No. 2016 13 2016 13” Financial Instruments-Credit Losses (Topic 326 Measurement of Credit Losses on Financial Instruments 2016 13 2016 13 December 30, 2019 no New Accounting Pronouncements In December 2019, No. 2019 12, Simplifying the Accounting for Income Taxes 740, 1 2 3 December 15, 2020. 2019 12, January 4, 2021, not In August 2020, No. 2020 06, Debt—Debt with Conversion and Other Options (Subtopic 470 20 815 40 December 15, 2021, not No. 2020 06 |
Note 4 - Balance Sheet Compon_2
Note 4 - Balance Sheet Components (Tables) | 12 Months Ended |
Jan. 03, 2021 | |
Notes Tables | |
Condensed Balance Sheet [Table Text Block] | January 3, December 29, 2021 2019 (in thousands) Inventories: Raw material $ 191 $ 222 Work-in-process 1,842 2,370 Finished goods 655 668 $ 2,688 $ 3,260 Other current assets: Prepaid expenses $ 884 $ 1,296 Other 182 269 $ 1,066 $ 1,565 Property and equipment: Equipment $ 10,471 $ 10,694 Software 1,783 1,789 Furniture and fixtures 33 36 Leasehold improvements 466 474 12,753 12,993 Accumulated depreciation and amortization (12,205 ) (12,163 ) $ 548 $ 830 Capitalized internal-use software: Capitalized software held for internal use $ 1,166 $ 365 Accumulated amortization (180 ) (32 ) $ 986 $ 333 Accrued liabilities: Employee compensation related accruals 762 713 Other 578 420 $ 1,340 $ 1,133 |
Note 6 - Intangible Assets (Tab
Note 6 - Intangible Assets (Tables) | 12 Months Ended |
Jan. 03, 2021 | |
Notes Tables | |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | Amount Annual Fiscal Years 2021 107 2022 107 2023 107 2024 107 2025 107 Thereafter 325 Total $ 860 |
Sensi ML [Member] | |
Notes Tables | |
Schedule of Finite-Lived Intangible Assets [Table Text Block] | January 3, 2021 Useful Life Gross Carrying Amount Accumulated Amortization Net Carrying Amount Developed technology 10 $ 959 $ (192 ) $ 767 Customer relationships 2 81 (81 ) — Trade names and trade marks 10 116 (23 ) 93 Total acquired identifiable intangible assets $ 1,156 $ (296 ) $ 860 December 29, 2019 Useful Life Gross Carrying Amount Accumulated Amortization Net Carrying Amount Developed technology 10 $ 959 $ (96 ) $ 863 Customer relationships 2 81 (40 ) 41 Trade names and trade marks 10 116 (12 ) 104 Total acquired identifiable intangible assets $ 1,156 $ (148 ) $ 1,008 |
Note 8 - Leases (Tables)
Note 8 - Leases (Tables) | 12 Months Ended |
Jan. 03, 2021 | |
Notes Tables | |
Lease, Cost [Table Text Block] | Fiscal Year Ended Fiscal Year Ended January 3, 2021 December 29, 2019 Operating lease costs: Fixed $ 473 $ 757 Variable — — Short term 20 40 Total 493 797 Finance lease costs: Amortization of ROU asset 315 388 Interest 38 18 Total $ 353 $ 406 |
Lessee, Leases, Supplemental Cash Flow Information [Table Text Block] | Fiscal Year Ended Fiscal Year Ended January 3, 2021 December 29, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used for operating leases $ 497 $ 791 Operating cash flows used for finance leases 38 24 Financing cash flows used for financing leases 270 365 Total $ 805 $ 1,180 Right-of-use assets obtained in exchange for obligations: Operating leases $ — $ 2,200 Finance leases 914 170 Total $ 914 $ 2,370 |
Schedule of Right of Use Assets and Lease Liabilities [Table Text Block] | January 3, 2021 December 29, 2019 Right-of-use assets: Operating leases $ 1,134 $ 2,200 Finance leases 705 170 Total $ 1,839 $ 2,370 Lease liabilities: Operating leases 1,212 1,816 Finance leases 670 471 Total $ 1,882 $ 2,287 |
Schedule of Future Lease Payments for Leases [Table Text Block] | Annual Fiscal Years Operating Finance 2021 $ 402 $ 375 2022 409 335 2023 422 — 2024 106 — Total lease payments 1,339 710 Less: Interest (127 ) (40 ) Present value of lease liabilities $ 1,212 $ 670 |
Schedule of Lease Terms and Weighted Average Discount Rate [Table Text Block] | January 3, 2021 Right-of-use assets: Weighted-average remaining lease term (years) Operating leases 3.24 Finance leases 2.21 Weighted-average discount rates: Operating leases 6.00 % Finance leases 5.50 % |
Note 10 - Income Taxes (Tables)
Note 10 - Income Taxes (Tables) | 12 Months Ended |
Jan. 03, 2021 | |
Notes Tables | |
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] | Fiscal Years 2020 2019 2018 Loss before income taxes: U.S. $ (11,170 ) $ (15,813 ) $ (13,982 ) Foreign 70 289 355 Loss before income taxes $ (11,100 ) $ (15,524 ) $ (13,627 ) Provision for (benefit from) income taxes: Current: Federal $ — $ — $ (19 ) State 3 3 2 Foreign 39 108 169 Subtotal 42 111 152 Deferred: Federal — (141 ) — State — (44 ) — Foreign 9 (6 ) — Subtotal 9 (191 ) — Provision for (benefit from) income taxes $ 51 $ (80 ) $ 152 |
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | Fiscal Years 2020 2019 2018 Income tax (benefit) at statutory rate $ (2,331 ) $ (3,260 ) $ (2,862 ) State taxes 3 (42 ) 2 Stock compensation and other permanent differences 99 187 252 Foreign taxes 34 42 95 Future benefit of deferred tax assets not recognized 2,246 3,133 2,684 Other — (140 ) (19 ) Provision for (benefit from) income taxes $ 51 $ (80 ) $ 152 |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | January 3, December 29, 2021 2019 Deferred tax assets: Net operating losses $ 43,703 $ 40,717 Accruals and reserves 1,239 1,345 Credits carryforward 5,860 5,765 Depreciation and amortization 9,240 9,760 Stock-based compensation 485 637 Operating lease liability 469 529 Gross deferred tax assets 60,996 58,753 Deferred tax liabilities: Right-of-use asset (458 ) (552 ) Gross deferred tax assets (458 ) (552 ) Net deferred tax assets 60,538 58,201 Valuation allowance (60,486 ) (58,140 ) Total deferred tax asset $ 52 $ 61 |
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] | January 3, December 29, December 30, 2021 2019 2018 Beginning balance of unrecognized tax benefits $ 2,117 $ 2,161 $ 2,107 Additions (subtractions) for tax positions related to the prior year 38 (46 ) (2 ) Additions for tax positions related to the current year 114 88 125 Lapse of statutes of limitations (93 ) (86 ) (69 ) Ending balance of unrecognized tax benefits $ 2,176 $ 2,117 $ 2,161 |
Note 13 - Stock-based Compens_2
Note 13 - Stock-based Compensation (Tables) | 12 Months Ended |
Jan. 03, 2021 | |
Notes Tables | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] | Fiscal Years 2020 2019 2018 Cost of revenue $ 162 $ 78 $ 129 Research and development 670 2,242 760 Selling, general and administrative 907 824 1,012 Total costs and expenses $ 1,739 $ 3,144 $ 1,901 |
Share-based Payment Arrangement, Activity [Table Text Block] | Shares Available for Grant Balance at December 29, 2019 272 Authorized 550 Options granted — Options forfeited or expired 65 RSUs granted (816 ) RSUs forfeited 249 Balance at January 3, 2021 320 |
Share-based Payment Arrangement, Option, Activity [Table Text Block] | Number of Shares Weighted Average Exercise Price Weighted Average Remaining Term Aggregate Intrinsic Value (in thousands) (in years) (in thousands) Balance outstanding at December 31, 2017 254 $ 29.26 4.34 Granted — — Forfeited or expired (10 ) 25.20 Exercised (15 ) 12.60 Balance outstanding at December 30, 2018 229 30.52 3.70 Granted — — Forfeited or expired (42 ) 24.14 Exercised (1 ) 10.92 Balance outstanding at December 29, 2019 186 32.09 3.32 Granted — — Forfeited or expired (65 ) 38.83 Exercised — — Balance outstanding at January 3, 2021 121 $ 28.46 3.75 $ — Exercisable and Vested and expected to vest at January 3, 2021 121 $ 28.46 3.75 $ — |
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] | Options Outstanding Options Exercisable Range of Exercise Prices Options Outstanding Weighted Average Remaining Contractual Life Weighted Average Exercise Price Options Vested and Exercisable Weighted Average Exercise Price (in thousands) (in years) (in thousands) $12.05 52 5.68 $ 12.05 52 $ 12.05 $18.48 - $31.50 14 2.82 26.71 14 26.71 $32.20 3 2.34 32.2 3 32.20 $38.92 14 0.85 38.92 14 38.92 $39.48 - $44.94 9 2.76 42.94 9 42.91 $46.62 3 3.34 46.62 3 46.62 $47.46 14 2.94 47.46 14 47.46 $48.72 8 1.35 48.72 8 48.72 $53.48 4 3.38 53.48 4 53.48 $12.05- $53.48 121 3.75 $ 28.46 121 $ 28.46 |
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] | RSUs & PRSUs Outstanding Number of Shares Weighted Average Grant Date Fair Value (in thousands) Nonvested at December 31, 2017 168 $ 21.56 Granted 110 11.90 Vested (77 ) 19.18 Forfeited (18 ) — Nonvested at December 30, 2018 183 17.22 Granted 353 10.77 Vested (118 ) 14.48 Forfeited (41 ) — Nonvested at December 29, 2019 377 $ 12.55 Granted 816 3.97 Vested (144 ) 10.41 Forfeited (249 ) 7.93 Nonvested at January 3, 2021 800 $ 4.99 |
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] | Fiscal Years 2020 2019 2018 Expected life (months) 6.0 6.0 6.0 Risk-free interest rate 0.12 % 2.37 % 2.26 % Volatility 82 % 54 % 50 % Dividend yield — — — |
Note 14 - Information Concern_2
Note 14 - Information Concerning Product Lines, Geographic Information, Accounts Receivable and Revenue Concentration (Tables) | 12 Months Ended |
Jan. 03, 2021 | |
Notes Tables | |
Revenue from External Customers by Products and Services [Table Text Block] | Fiscal Years 2020 2019 2018 Revenue by product line (1) : New products $ 2,782 $ 3,123 $ 5,735 Mature products 5,852 7,187 6,894 Total revenue $ 8,634 $ 10,310 $ 12,629 |
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] | Fiscal Years 2020 2019 2018 Revenue by geography: Asia Pacific (1) $ 2,096 $ 3,049 $ 4,905 Europe 1,501 2,459 1,280 North America (2) 5,037 4,802 6,444 Total revenue $ 8,634 $ 10,310 $ 12,629 |
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] | Fiscal Years 2020 2019 2018 Distributor "A" 24 % 40 % 34 % Distributor "C" 15 % 13 % * Distributor "E" 19 % * * Customer "B" 10 % 13 % 12 % Customer "E" * 10 % * Customer "F" 19 % * * Customer "G" * * 10 % Customer "J" * * 10 % Customer "M" 16 % * * January 3, December 29, 2021 2019 Distributor "A" * 20 % Distributor "C" * 23 % Distributor "E" * 12 % Distributor "J" * 31 % Customer "P" 67 % * Customer "Q" 10 % * |
Schedule II - Valuation and Q_2
Schedule II - Valuation and Qualifying Accounts (Tables) | 12 Months Ended |
Jan. 03, 2021 | |
Notes Tables | |
Summary of Valuation Allowance [Table Text Block] | Allowance for Deferred Tax Assets: Fiscal Year 2020 $ 58,140 $ 2,398 $ — $ 60,538 Fiscal Year 2019 $ 54,913 $ 3,227 $ — $ 58,140 Fiscal Year 2018 $ 55,931 $ — $ (1,018 ) $ 54,913 |
Note 1 - The Company and Basi_2
Note 1 - The Company and Basis of Presentation (Details Textual) | Dec. 11, 2020 | Jun. 22, 2020USD ($)$ / sharesshares | Dec. 06, 2019 | Nov. 26, 2019 | Nov. 25, 2019 | Nov. 06, 2019USD ($) | Jun. 21, 2019USD ($)$ / sharesshares | Dec. 21, 2018USD ($) | Jul. 21, 2020USD ($)shares | May 31, 2018$ / sharesshares | Jan. 03, 2021USD ($)$ / sharesshares | Dec. 29, 2019USD ($)$ / sharesshares | Dec. 30, 2018USD ($)shares | Sep. 28, 2019USD ($) | Dec. 20, 2018USD ($) | Sep. 28, 2018USD ($) | |
Restructuring Costs, Total | $ 753,000 | $ 0 | $ 0 | ||||||||||||||
Cash and Cash Equivalents, at Carrying Value, Ending Balance | 22,748,000 | 21,548,000 | |||||||||||||||
Line of Credit, Current | $ 15,000,000 | $ 15,000,000 | |||||||||||||||
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | |||||||||||||||
Proceeds from Issuance of Common Stock | $ 9,296,000 | $ 9,437,000 | $ 16,215,000 | ||||||||||||||
Reverse Stock Split Ratio, Authorized | 15 | 5 | |||||||||||||||
Reverse Stock Split [Member] | |||||||||||||||||
Stockholders' Equity Note, Stock Split, Conversion Ratio | 14 | ||||||||||||||||
Underwritten Public Offering [Member] | |||||||||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | shares | 965,251 | ||||||||||||||||
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | |||||||||||||||
Common Stock [Member] | |||||||||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | shares | [1] | 2,642,000 | 1,314,000 | 965,000 | |||||||||||||
Common Stock [Member] | Underwritten Public Offering [Member] | |||||||||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | shares | 2,500,000 | 1,300,000 | |||||||||||||||
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | |||||||||||||||
Shares Issued, Price Per Share (in dollars per share) | $ / shares | $ 3.50 | $ 7 | |||||||||||||||
Proceeds from Issuance of Common Stock | $ 8,800,000 | $ 8,000,000 | $ 8,100,000 | ||||||||||||||
Common Stock [Member] | Exercise of Option for Overallotment of Shares by Underwriters [Member] | |||||||||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | shares | 375,000 | 171,429 | 141,733 | ||||||||||||||
Proceeds from Issuance of Common Stock | $ 496,000 | ||||||||||||||||
Heritage Bank of Commerce [Member] | Revolving Credit Facility [Member] | |||||||||||||||||
Cash and Cash Equivalents, at Carrying Value, Ending Balance | $ 22,600,000 | ||||||||||||||||
Line of Credit, Current | $ 15,000,000 | $ 15,000,000 | |||||||||||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 15,000,000 | $ 9,000,000 | $ 9,000,000 | $ 9,000,000 | |||||||||||||
Minimum Cash Required for Covenant Related to Credit Facility | $ 3,000,000 | $ 3,000,000 | |||||||||||||||
Line of Credit Facility, Expiration Period (Year) | 1 year | 1 year | 1 year | ||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 5.50% | ||||||||||||||||
Debt Instrument, Interest Rate, Effective Percentage | 3.75% | 5.50% | |||||||||||||||
Heritage Bank of Commerce [Member] | Revolving Credit Facility [Member] | Prime Rate [Member] | |||||||||||||||||
Debt Instrument, Basis Spread on Variable Rate | 0.50% | 0.50% | |||||||||||||||
[1] | Common stock, par value and additional paid-in capital amounts are adjusted to reflect 1-for-14 reverse stock split effected on December 23, 2019. |
Note 2 - Significant Accounti_2
Note 2 - Significant Accounting Policies (Details Textual) | 12 Months Ended | ||||
Jan. 03, 2021USD ($) | Dec. 29, 2019USD ($) | Dec. 30, 2018USD ($) | Jan. 03, 2020USD ($) | Mar. 31, 2019USD ($) | |
Operating Expenses, Denominated in Foreign Currency, Percent | 18.00% | 19.00% | 27.00% | ||
Asset Impairment Charges, Total | $ 44,000 | $ 4,000 | $ 5,000 | ||
Revenue from Contract with Customer, Valuation Allowances And Reserves, Sales Return | 30,000 | 60,000 | |||
Operating Lease, Right-of-Use Asset | 1,134,000 | 2,200,000 | |||
Goodwill, Ending Balance | 185,000 | 185,000 | |||
Deferred Tax Assets, Gross, Total | 60,996,000 | 58,753,000 | |||
Deferred Tax Assets, Valuation Allowance, Total | $ 60,486,000 | 58,140,000 | $ 60,000,000 | ||
Number of suppliers | 1 | ||||
Sensi ML [Member] | |||||
Goodwill, Ending Balance | 185,000 | ||||
Other Noncurrent Assets [Member] | |||||
Operating Lease, Right-of-Use Asset | $ 1,800,000 | $ 975,000 | |||
Other Liabilities [Member] | |||||
Operating Lease, Liability, Total | $ 1,900,000 | $ 939,000 | |||
Licensed Intellectual Property [Member] | |||||
Finite-Lived Intangible Asset, Useful Life (Year) | 5 years | ||||
Restructuring Charges [Member] | |||||
Asset Impairment Charges, Total | $ 35,000 | ||||
Restructuring Charges [Member] | INDIA | |||||
Operating Lease, Impairment Loss | 93,000 | ||||
Selling, General and Administrative Expenses [Member] | |||||
Marketing and Advertising Expense, Total | $ 76,000 | $ 146,000 | $ 93,000 | ||
Minimum [Member] | |||||
Property, Plant and Equipment, Useful Life (Year) | 1 year | ||||
Minimum [Member] | Leasehold Improvements [Member] | |||||
Property, Plant and Equipment, Useful Life (Year) | 1 year | ||||
Maximum [Member] | |||||
Property, Plant and Equipment, Useful Life (Year) | 7 years | ||||
Finite-Lived Intangible Asset, Useful Life (Year) | 5 years | ||||
Maximum [Member] | Leasehold Improvements [Member] | |||||
Property, Plant and Equipment, Useful Life (Year) | 7 years |
Note 3 - Net Loss Per Share (De
Note 3 - Net Loss Per Share (Details Textual) | Dec. 06, 2019 | Jan. 03, 2021shares | Dec. 29, 2019shares | Dec. 30, 2018shares | May 29, 2018shares |
Reverse Stock Split [Member] | |||||
Stockholders' Equity Note, Stock Split, Conversion Ratio | 14 | ||||
Common Stock [Member] | Maximum [Member] | |||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 386,000 | ||||
Share-based Payment Arrangement [Member] | |||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | 921,000 | 563,000 | 435,000 |
Note 4 - Balance Sheet Compon_3
Note 4 - Balance Sheet Components (Details Textual) - USD ($) | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | |
Depreciation, Amortization and Accretion, Net, Total | $ 817,000 | $ 1,201,000 | $ 1,276,000 |
Interest Costs Capitalized | 0 | 0 | $ 0 |
Capitalized Computer Software, Amortization | $ 148,000 | $ 32,000 |
Note 4 - Balance Sheet Compon_4
Note 4 - Balance Sheet Components - Balance Sheet Components (Details) - USD ($) $ in Thousands | Jan. 03, 2021 | Dec. 29, 2019 |
Inventories: | ||
Raw material | $ 191 | $ 222 |
Work-in-process | 1,842 | 2,370 |
Finished goods | 655 | 668 |
Inventory, Net, Total | 2,688 | 3,260 |
Other current assets: | ||
Prepaid expenses | 884 | 1,296 |
Other | 182 | 269 |
Other Assets, Current | 1,066 | 1,565 |
Property and equipment: | ||
Property and equipment, gross | 12,753 | 12,993 |
Accumulated depreciation and amortization | (12,205) | (12,163) |
Property, Plant and Equipment, Net, Ending Balance | 548 | 830 |
Capitalized internal-use software: | ||
Capitalized software held for internal use | 1,166 | 365 |
Accumulated amortization | (180) | (32) |
Capitalized Computer Software, Net, Ending Balance | 986 | 333 |
Accrued liabilities: | ||
Employee compensation related accruals | 762 | 713 |
Other | 578 | 420 |
Accrued Liabilities, Current, Total | 1,340 | 1,133 |
Equipment [Member] | ||
Property and equipment: | ||
Property and equipment, gross | 10,471 | 10,694 |
Software [Member] | ||
Property and equipment: | ||
Property and equipment, gross | 1,783 | 1,789 |
Furniture and Fixtures [Member] | ||
Property and equipment: | ||
Property and equipment, gross | 33 | 36 |
Leasehold Improvements [Member] | ||
Property and equipment: | ||
Property and equipment, gross | $ 466 | $ 474 |
Note 5 - Business Acquisition (
Note 5 - Business Acquisition (Details Textual) - USD ($) | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Jan. 02, 2020 | |
Goodwill, Ending Balance | $ 185,000 | $ 185,000 | |
Sensi ML [Member] | |||
Revenues, Total | 175,000 | 126,000 | |
Amortization of Intangible Assets, Total | $ 148,000 | 148,000 | |
Business Combination, Acquisition Related Costs | 104,000 | ||
Goodwill, Ending Balance | $ 185,000 | ||
Escrow Deposit | $ 200,000 |
Note 6 - Intangible Assets - Sc
Note 6 - Intangible Assets - Schedule of Carrying Value of Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Jan. 03, 2021 | Dec. 29, 2019 | |
Net Carrying Amount | $ 860 | |
Sensi ML [Member] | ||
Gross Carrying Amount | 1,156 | $ 1,156 |
Accumulated Amortization | (296) | (148) |
Net Carrying Amount | $ 860 | $ 1,008 |
Sensi ML [Member] | Developed Technology Rights [Member] | ||
Finite-Lived Intangible Asset, Useful Life (Year) | 10 years | 10 years |
Gross Carrying Amount | $ 959 | $ 959 |
Accumulated Amortization | (192) | (96) |
Net Carrying Amount | $ 767 | $ 863 |
Sensi ML [Member] | Customer Relationships [Member] | ||
Finite-Lived Intangible Asset, Useful Life (Year) | 2 years | 2 years |
Gross Carrying Amount | $ 81 | $ 81 |
Accumulated Amortization | (81) | (40) |
Net Carrying Amount | $ 0 | $ 41 |
Sensi ML [Member] | Trademarks and Trade Names [Member] | ||
Finite-Lived Intangible Asset, Useful Life (Year) | 10 years | 10 years |
Gross Carrying Amount | $ 116 | $ 116 |
Accumulated Amortization | (23) | (12) |
Net Carrying Amount | $ 93 | $ 104 |
Note 6 - Intangible Assets - _2
Note 6 - Intangible Assets - Schedule of Expected Future Annual Amortization of Intangible Assets (Details) $ in Thousands | Jan. 03, 2021USD ($) |
2021 | $ 107 |
2022 | 107 |
2023 | 107 |
2024 | 107 |
2025 | 107 |
Thereafter | 325 |
Total | $ 860 |
Note 7 - Debt Obligations (Deta
Note 7 - Debt Obligations (Details Textual) - USD ($) $ in Millions | Dec. 11, 2020 | Nov. 06, 2019 | Dec. 21, 2018 | Jan. 03, 2021 | May 06, 2020 | Dec. 29, 2019 | Sep. 28, 2019 | Dec. 20, 2018 | Sep. 28, 2018 |
Line of Credit, Current | $ 15 | $ 15 | |||||||
Heritage Bank of Commerce [Member] | Paycheck Protection Program [Member] | |||||||||
Debt Instrument, Interest Rate, Stated Percentage | 1.00% | ||||||||
Debt Instrument, Face Amount | 1.2 | $ 1.2 | |||||||
Heritage Bank of Commerce [Member] | Revolving Credit Facility [Member] | |||||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 15 | $ 9 | $ 9 | $ 9 | |||||
Minimum Cash Required for Covenant Related to Credit Facility | $ 3 | $ 3 | |||||||
Line of Credit Facility, Expiration Period (Year) | 1 year | 1 year | 1 year | ||||||
Debt Instrument, Interest Rate, Stated Percentage | 5.50% | ||||||||
Line of Credit, Current | $ 15 | $ 15 | |||||||
Debt Instrument, Interest Rate, Effective Percentage | 3.75% | 5.50% | |||||||
Heritage Bank of Commerce [Member] | Revolving Credit Facility [Member] | Prime Rate [Member] | |||||||||
Debt Instrument, Basis Spread on Variable Rate | 0.50% | 0.50% |
Note 8 - Leases (Details Textua
Note 8 - Leases (Details Textual) | 12 Months Ended | ||||
Jan. 03, 2021USD ($)ft² | Dec. 29, 2019USD ($) | Dec. 30, 2018USD ($) | Jul. 10, 2020ft² | Feb. 13, 2019ft² | |
Operating and Finance Lease, Right of Use Asset | $ | $ 1,839,000 | $ 2,370,000 | |||
Operating and Finance Lease Liability | $ | 1,882,000 | 2,287,000 | |||
Operating Lease, Expense | $ | $ 493,000 | $ 798,000 | $ 881,000 | ||
Office In California [Member] | |||||
Lessee, Operating Lease, Term of Contract (Year) | 5 years | ||||
Area of Land (Square Foot) | ft² | 24,164 | ||||
Office in India [Member] | |||||
Lessee, Operating Lease, Term of Contract (Year) | 11 years | ||||
Area of Real Estate Property (Square Foot) | ft² | 9,400 | ||||
Office Premises in India [Member] | |||||
Area of Real Estate Property (Square Foot) | ft² | 1,100 | ||||
Minimum [Member] | |||||
Lessee, Operating Lease, Term of Contract (Year) | 1 year | ||||
Lessee, Finance Lease, Term of Contract (Year) | 2 years | ||||
Maximum [Member] | |||||
Lessee, Operating Lease, Term of Contract (Year) | 5 years | ||||
Lessee, Finance Lease, Term of Contract (Year) | 3 years |
Note 8 - Leases - Summary of Op
Note 8 - Leases - Summary of Operating and Finance Leases (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Jan. 03, 2021 | Dec. 29, 2019 | |
Fixed | $ 473 | $ 757 |
Variable | 0 | 0 |
Short term | 20 | 40 |
Total | 493 | 797 |
Amortization of ROU asset | 315 | 388 |
Interest | 38 | 18 |
Total | $ 353 | $ 406 |
Note 8 - Leases - Summary of Su
Note 8 - Leases - Summary of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 29, 2019 | Dec. 30, 2018 | |
Operating cash flows used for operating leases | $ 497 | $ 791 | ||
Operating cash flows used for finance leases | 38 | 24 | ||
Financing cash flows used for financing leases | 270 | 365 | $ 365 | $ 407 |
Total | 805 | 1,180 | ||
Operating leases | 0 | 2,200 | ||
Finance leases | 914 | 170 | ||
Total | $ 914 | $ 2,370 |
Note 8 - Leases - Details of Ri
Note 8 - Leases - Details of Right-of-Use Assets and Lease Liabilities (Details) - USD ($) $ in Thousands | Jan. 03, 2021 | Dec. 29, 2019 |
Operating Lease, Right-of-Use Asset | $ 1,134 | $ 2,200 |
Finance leases | 705 | 170 |
Total | 1,839 | 2,370 |
Finance leases | 670 | 471 |
Total | 1,882 | 2,287 |
Current and Lease Liabilities - Non-current [Member] | ||
Operating Lease, Liability, Total | $ 1,212 | $ 1,816 |
Note 8 - Leases - Schedule of F
Note 8 - Leases - Schedule of Future Lease Payments for Leases (Details) - USD ($) $ in Thousands | Jan. 03, 2021 | Dec. 29, 2019 |
2021 | $ 402 | |
2021 | 375 | |
2022 | 409 | |
2022 | 335 | |
2023 | 422 | |
2023 | 0 | |
2024 | 106 | |
2024 | 0 | |
Total lease payments, operating | 1,339 | |
Total lease payments, finance | 710 | |
Less: Interest, operating | (127) | |
Less: Interest, finance | (40) | |
Present value of lease liabilities, finance | 670 | $ 471 |
Current and Lease Liabilities - Non-current [Member] | ||
Present value of lease liabilities, operating | $ 1,212 | $ 1,816 |
Note 8 - Leases - Schedule of L
Note 8 - Leases - Schedule of Lease Terms and Weighted Average Discount Rate (Details) | Jan. 03, 2021 |
Operating leases (Year) | 3 years 2 months 26 days |
Finance leases (Year) | 2 years 2 months 15 days |
Operating leases | 6.00% |
Finance leases | 5.50% |
Note 9 - Fair Value Measureme_2
Note 9 - Fair Value Measurements (Details Textual) - USD ($) $ in Millions | Jan. 03, 2021 | Dec. 29, 2020 |
Money Market Funds [Member] | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | ||
Cash and Cash Equivalents, Fair Value Disclosure | $ 22 | $ 20.9 |
Note 10 - Income Taxes (Details
Note 10 - Income Taxes (Details Textual) - USD ($) $ in Thousands | Dec. 22, 2017 | Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | Jan. 01, 2018 | Dec. 31, 2017 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 35.00% | 21.00% | ||||
Unrecognized Tax Benefits, Ending Balance | $ 2,176 | $ 2,117 | $ 2,161 | $ 2,107 | ||
Unrecognized Tax Benefits that Would Impact Effective Tax Rate | 0 | |||||
Federal [Member] | ||||||
Operating Loss Carryforwards, Total | 181,100 | $ 39,200 | $ 141,600 | |||
Federal [Member] | Research Tax Credit Carryforward [Member] | ||||||
Tax Credit Carryforward, Amount | 4,100 | |||||
State and Local Jurisdiction [Member] | ||||||
Operating Loss Carryforwards, Total | 81,000 | |||||
State and Local Jurisdiction [Member] | Research Tax Credit Carryforward [Member] | ||||||
Tax Credit Carryforward, Amount | $ 4,600 |
Note 10 - Income Taxes - Compon
Note 10 - Income Taxes - Components of Income Tax Expense Benefit (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | |
Income (loss) before income taxes | $ (11,100) | $ (15,524) | $ (13,627) |
Federal | 0 | 0 | (19) |
State | 3 | 3 | 2 |
Foreign | 39 | 108 | 169 |
Subtotal | 42 | 111 | 152 |
Federal | 0 | (141) | 0 |
State | 0 | (44) | 0 |
Foreign | 9 | (6) | 0 |
Subtotal | 9 | (191) | 0 |
Provision for (benefit from) income taxes | 51 | (80) | 152 |
Domestic Tax Authority [Member] | |||
U.S. | (11,170) | (15,813) | (13,982) |
Foreign Tax Authority [Member] | |||
Foreign | $ 70 | $ 289 | $ 355 |
Note 10 - Income Taxes - Effect
Note 10 - Income Taxes - Effective Tax Rate Reconciliation (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | |
Income tax (benefit) at statutory rate | $ (2,331) | $ (3,260) | $ (2,862) |
State taxes | 3 | (42) | 2 |
Stock compensation and other permanent differences | 99 | 187 | 252 |
Foreign taxes | 34 | 42 | 95 |
Future benefit of deferred tax assets not recognized | 2,246 | 3,133 | 2,684 |
Other | 0 | (140) | (19) |
Provision for (benefit from) income taxes | $ 51 | $ (80) | $ 152 |
Note 10 - Income Taxes - Deferr
Note 10 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands | Jan. 03, 2021 | Jan. 03, 2020 | Dec. 29, 2019 |
Net operating losses | $ 43,703 | $ 40,717 | |
Accruals and reserves | 1,239 | 1,345 | |
Credits carryforward | 5,860 | 5,765 | |
Depreciation and amortization | 9,240 | 9,760 | |
Stock-based compensation | 485 | 637 | |
Operating lease liability | 469 | 529 | |
Gross deferred tax assets | 60,996 | 58,753 | |
Right-of-use asset | (458) | (552) | |
Gross deferred tax assets | (458) | (552) | |
Net deferred tax assets | 60,538 | 58,201 | |
Valuation allowance | (60,486) | $ (60,000) | (58,140) |
Total deferred tax asset | $ 52 | $ 61 |
Note 10 - Income Taxes - Unreco
Note 10 - Income Taxes - Unrecognized Tax Benefits Roll Forward (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | |
Beginning balance of unrecognized tax benefits | $ 2,117 | $ 2,161 | $ 2,107 |
Additions for tax positions related to the prior year | 38 | ||
subtractions for tax positions related to the prior year | (46) | (2) | |
Additions for tax positions related to the current year | 114 | 88 | 125 |
Lapse of statutes of limitations | (93) | (86) | (69) |
Ending balance of unrecognized tax benefits | $ 2,176 | $ 2,117 | $ 2,161 |
Note 11 - Stockholders' Equity
Note 11 - Stockholders' Equity (Details Textual) | Jun. 22, 2020USD ($)$ / sharesshares | Dec. 06, 2019 | Jun. 21, 2019USD ($)$ / sharesshares | May 29, 2018yr$ / sharesshares | Jul. 21, 2020USD ($)shares | May 31, 2018USD ($)$ / sharesshares | Jan. 03, 2021USD ($)$ / sharesshares | Dec. 29, 2019USD ($)$ / sharesshares | Dec. 30, 2018USD ($)shares | Mar. 15, 2019USD ($) | |
Common Stock, Shares Authorized (in shares) | shares | 200,000,000 | 200,000,000 | |||||||||
Preferred Stock, Shares Authorized (in shares) | shares | 10,000,000 | 10,000,000 | |||||||||
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | |||||||||
Proceeds from Issuance of Common Stock | $ 9,296,000 | $ 9,437,000 | $ 16,215,000 | ||||||||
Payments of Stock Issuance Costs | $ 1,147,000 | $ 1,181,000 | $ 1,638,000 | ||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 19.32 | ||||||||||
Class of Warrant or Right, Outstanding (in shares) | shares | 386,100 | ||||||||||
Warrants Issued in Connection with Underwritten Public Offering [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares) | shares | 0.40 | ||||||||||
Warrants and Rights Outstanding, Term (Month) | 60 months | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 19.32 | ||||||||||
Class of Warrant or Right, Estimated Grant Date Fair Value (in dollars per share) | $ / shares | $ 7.98 | ||||||||||
Warrants Issued in Connection with Underwritten Public Offering [Member] | Measurement Input, Expected Term [Member] | |||||||||||
Warrants and Rights Outstanding, Measurement Input (Year) | yr | 5 | ||||||||||
Warrants Issued in Connection with Underwritten Public Offering [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||||||
Warrants and Rights Outstanding, Measurement Input (Year) | 0.0258 | ||||||||||
Warrants Issued in Connection with Underwritten Public Offering [Member] | Measurement Input, Price Volatility [Member] | |||||||||||
Warrants and Rights Outstanding, Measurement Input (Year) | 0.5275 | ||||||||||
Warrants Issued in Connection with Underwritten Public Offering [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||||||
Warrants and Rights Outstanding, Measurement Input (Year) | 0 | ||||||||||
Maximum [Member] | Warrants Issued in Connection with Underwritten Public Offering [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares | 386,100 | ||||||||||
Common Stock [Member] | |||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | shares | [1] | 2,642,000 | 1,314,000 | 965,000 | |||||||
Common Stock [Member] | Maximum [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares | 386,000 | ||||||||||
Underwritten Public Offering [Member] | |||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | shares | 965,251 | ||||||||||
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | |||||||||
Equity Offering Units, Issued, Price Per Unit | 16.10 | ||||||||||
Proceeds from Issuance or Sale of Equity, Total | $ 13,900,000 | ||||||||||
Underwritten Public Offering [Member] | Common Stock [Member] | |||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | shares | 2,500,000 | 1,300,000 | |||||||||
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | |||||||||
Shares Issued, Price Per Share (in dollars per share) | $ / shares | $ 3.50 | $ 7 | |||||||||
Proceeds from Issuance of Common Stock | $ 8,800,000 | $ 8,000,000 | $ 8,100,000 | ||||||||
Payments of Stock Issuance Costs | $ 1,100,000 | ||||||||||
Shelf Registration Maximum Offering | $ 75,000,000 | ||||||||||
Number Of Common Stocks, Issued, Units (in shares) | shares | 1 | ||||||||||
Exercise of Option for Overallotment of Shares by Underwriters [Member] | Common Stock [Member] | |||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | shares | 375,000 | 171,429 | 141,733 | ||||||||
Proceeds from Issuance of Common Stock | $ 496,000 | ||||||||||
Payments of Stock Issuance Costs | 52,000 | ||||||||||
Underwritten Public Offering, Including Exercise of Overallotment Options by Underwriters [Member] | Common Stock [Member] | |||||||||||
Proceeds from Issuance of Common Stock | 9,300,000 | ||||||||||
Payments of Stock Issuance Costs | 1,200,000 | ||||||||||
Proceeds from Issuance of Common Stock, Net | $ 8,100,000 | ||||||||||
Reverse Stock Split [Member] | |||||||||||
Stockholders' Equity Note, Stock Split, Conversion Ratio | 14 | ||||||||||
[1] | Common stock, par value and additional paid-in capital amounts are adjusted to reflect 1-for-14 reverse stock split effected on December 23, 2019. |
Note 12 - Employee Stock Plans
Note 12 - Employee Stock Plans (Details Textual) - shares | Apr. 24, 2019 | Apr. 25, 2018 | Apr. 26, 2017 | Apr. 23, 2015 | Dec. 22, 2017 | Jan. 03, 2021 |
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) | 10 years | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) | 4 years | |||||
Stock Plan 2009 [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized (in shares) | 285,714 | 178,571 | 107,143 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) | 10 years | |||||
Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation (in shares) | 299,070 | |||||
Stock Plan 2019 [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized (in shares) | 550,000 | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) | 357,143 | 319,341 | ||||
Stock Plan 2019 [Member] | Restricted Stock Units (RSUs) [Member] | Share-based Payment Arrangement, Tranche One [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 25.00% | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) | 1 year | |||||
The 2009 Employee Stock Purchase Plan [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized (in shares) | 107,143 | 71,429 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) | 341,948 | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Offering Period (Month) | 6 months | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate | 20.00% | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee (in shares) | 1,429 | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date | 85.00% |
Note 13 - Stock-based Compens_3
Note 13 - Stock-based Compensation (Details Textual) - USD ($) | 12 Months Ended | |||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) | 4 years | |||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) | 10 years | |||
Share-based Payment Arrangement, Amount Capitalized | $ 0 | $ 0 | $ 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ 0 | |||
Share Price (in dollars per share) | $ 3.79 | |||
Proceeds from Stock Options Exercised | $ 0 | 3,600 | 195,000 | |
Share-based Payment Arrangement, Expense | 1,739,000 | $ 3,144,000 | $ 1,901,000 | |
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | $ 38,000 | |||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) | 0 years | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | 0 | 0 | 0 | |
Employee Stock Purchase Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance (in dollars per share) | $ 1.09 | $ 4.28 | $ 5.18 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 20,409 | 24,131 | 31,306 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ 2.47 | $ 9.76 | $ 15.40 | |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) | 341,926 | |||
Employee Stock Ownership Plan (ESOP), Compensation Expense | $ 39,000 | $ 60,000 | $ 205,000 | |
Share-based Payment Arrangement, Option [Member] | ||||
Share-based Payment Arrangement, Expense | $ 39,000 | $ 117,000 | $ 131,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | 0 | 0 | 0 | |
Restricted Stock Units (RSUs) [Member] | ||||
Share-based Payment Arrangement, Expense | $ 1,700,000 | $ 3,000,000 | $ 1,600,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance (in dollars per share) | $ 4.99 | $ 12.55 | $ 17.22 | $ 21.56 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 816,000 | 353,000 | 110,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ 3.97 | $ 10.77 | $ 11.90 |
Note 13 - Stock-based Compens_4
Note 13 - Stock-based Compensation - Schedule of Allocation of Recognized Period Cost (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | |
Total costs and expenses | $ 1,739 | $ 3,144 | $ 1,901 |
Cost of Sales [Member] | |||
Total costs and expenses | 162 | 78 | 129 |
Research and Development Expense [Member] | |||
Total costs and expenses | 670 | 2,242 | 760 |
Selling, General and Administrative Expenses [Member] | |||
Total costs and expenses | $ 907 | $ 824 | $ 1,012 |
Note 13 - Stock-based Compens_5
Note 13 - Stock-based Compensation - Schedule of Stock Based Compensation Award Activity (Details) - shares shares in Thousands | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | |
Balance (in shares) | 186 | 229 | 254 |
Options granted (in shares) | 0 | 0 | 0 |
Balance (in shares) | 121 | 186 | 229 |
Stock Plan 2019 [Member] | |||
Balance (in shares) | 272 | ||
Authorized (in shares) | 550 | ||
Options granted (in shares) | 0 | ||
Options forfeited or expired (in shares) | 65 | ||
Granted (in shares) | (816) | ||
RSUs forfeited (in shares) | 249 | ||
Balance (in shares) | 320 | 272 |
Note 13 - Stock-Based Compens_6
Note 13 - Stock-Based Compensation - Stock Options Activity (Details) - USD ($) | 12 Months Ended | |||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | Dec. 31, 2017 | |
Balance (in shares) | 186,000 | 229,000 | 254,000 | |
Weighted average price balance (in dollars per share) | $ 32.09 | $ 30.52 | $ 29.26 | |
Weighted average remaining, balance (Year) | 3 years 9 months | 3 years 3 months 25 days | 3 years 8 months 12 days | 4 years 4 months 2 days |
Options granted (in shares) | 0 | 0 | 0 | |
Weighted average price, granted (in dollars per share) | $ 0 | $ 0 | $ 0 | |
Forfeited or expired (in shares) | (65,000) | (42,000) | (10,000) | |
Weighted average price, forfeited or expired (in dollars per share) | $ 38.83 | $ 24.14 | $ 25.20 | |
Exercised, options (in shares) | 0 | (1,000) | (15,000) | |
Weighted average price, exercised (in dollars per share) | $ 0 | $ 10.92 | $ 12.60 | |
Balance (in shares) | 121,000 | 186,000 | 229,000 | 254,000 |
Weighted average price balance (in dollars per share) | $ 28.46 | $ 32.09 | $ 30.52 | $ 29.26 |
Aggregate intrinsic value, balance | $ 0 | |||
Exercisable and Vested and expected to vest, options (in shares) | 121 | |||
Weighted average price, exercisable and Vested and expected to vest (in dollars per share) | $ 28.46 | |||
Weighted average remaining, exercisable and Vested and expected to vest (Year) | 3 years 9 months | |||
Aggregate intrinsic value, exercisable and Vested and expected to vest | $ 0 |
Note 13 - Stock-Based Compens_7
Note 13 - Stock-Based Compensation - Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range (Details) | 12 Months Ended |
Jan. 03, 2021$ / sharesshares | |
Range 1 [Member] | |
Options Outstanding - Lower Limit (in dollars per share) | |
Options Outstanding (in shares) | shares | 52,000 |
Weighted Average Remaining Contractual Life (Year) | 5 years 8 months 4 days |
Weighted Average Exercise Price (in dollars per share) | $ 12.05 |
Options Exercisable (in shares) | shares | 52,000 |
Options, Weighted Average Exercise Price (in dollars per share) | $ 12.05 |
Range 2 [Member] | |
Options Outstanding - Lower Limit (in dollars per share) | |
Options Outstanding (in shares) | shares | 14,000 |
Weighted Average Remaining Contractual Life (Year) | 2 years 9 months 25 days |
Weighted Average Exercise Price (in dollars per share) | $ 26.71 |
Options Exercisable (in shares) | shares | 14,000 |
Options, Weighted Average Exercise Price (in dollars per share) | $ 26.71 |
Range 3 [Member] | |
Options Outstanding - Lower Limit (in dollars per share) | |
Options Outstanding (in shares) | shares | 3 |
Weighted Average Remaining Contractual Life (Year) | 2 years 4 months 2 days |
Weighted Average Exercise Price (in dollars per share) | $ 32.2 |
Options Exercisable (in shares) | shares | 3 |
Options, Weighted Average Exercise Price (in dollars per share) | $ 32.20 |
Range 4 [Member] | |
Options Outstanding - Lower Limit (in dollars per share) | |
Options Outstanding (in shares) | shares | 14,000 |
Weighted Average Remaining Contractual Life (Year) | 10 months 6 days |
Weighted Average Exercise Price (in dollars per share) | $ 38.92 |
Options Exercisable (in shares) | shares | 14,000 |
Options, Weighted Average Exercise Price (in dollars per share) | $ 38.92 |
Range 5 [Member] | |
Options Outstanding - Lower Limit (in dollars per share) | |
Options Outstanding (in shares) | shares | 9,000 |
Weighted Average Remaining Contractual Life (Year) | 2 years 9 months 3 days |
Weighted Average Exercise Price (in dollars per share) | $ 42.94 |
Options Exercisable (in shares) | shares | 9,000 |
Options, Weighted Average Exercise Price (in dollars per share) | $ 42.91 |
Range 6 [Member] | |
Options Outstanding - Lower Limit (in dollars per share) | |
Options Outstanding (in shares) | shares | 3,000 |
Weighted Average Remaining Contractual Life (Year) | 3 years 4 months 2 days |
Weighted Average Exercise Price (in dollars per share) | $ 46.62 |
Options Exercisable (in shares) | shares | 3,000 |
Options, Weighted Average Exercise Price (in dollars per share) | $ 46.62 |
Range 8 [Member] | |
Options Outstanding - Lower Limit (in dollars per share) | |
Options Outstanding (in shares) | shares | 14,000 |
Weighted Average Remaining Contractual Life (Year) | 2 years 11 months 8 days |
Weighted Average Exercise Price (in dollars per share) | $ 47.46 |
Options Exercisable (in shares) | shares | 14,000 |
Options, Weighted Average Exercise Price (in dollars per share) | $ 47.46 |
Range 9 [Member] | |
Options Outstanding - Lower Limit (in dollars per share) | |
Options Outstanding (in shares) | shares | 8,000 |
Weighted Average Remaining Contractual Life (Year) | 1 year 4 months 6 days |
Weighted Average Exercise Price (in dollars per share) | $ 48.72 |
Options Exercisable (in shares) | shares | 8,000 |
Options, Weighted Average Exercise Price (in dollars per share) | $ 48.72 |
Range 10 [Member] | |
Options Outstanding - Lower Limit (in dollars per share) | |
Options Outstanding (in shares) | shares | 4,000 |
Weighted Average Remaining Contractual Life (Year) | 3 years 4 months 17 days |
Weighted Average Exercise Price (in dollars per share) | $ 53.48 |
Options Exercisable (in shares) | shares | 4,000 |
Options, Weighted Average Exercise Price (in dollars per share) | $ 53.48 |
Range 11 [Member] | |
Options Outstanding - Lower Limit (in dollars per share) | |
Options Outstanding (in shares) | shares | 121,000 |
Weighted Average Remaining Contractual Life (Year) | 3 years 9 months |
Weighted Average Exercise Price (in dollars per share) | $ 28.46 |
Options Exercisable (in shares) | shares | 121,000 |
Options, Weighted Average Exercise Price (in dollars per share) | $ 28.46 |
Note 13 - Stock-Based Compens_8
Note 13 - Stock-Based Compensation - Summary of Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares shares in Thousands | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | |
Balance (in shares) | 377 | 183 | 168 |
Balance (in dollars per share) | $ 12.55 | $ 17.22 | $ 21.56 |
Granted (in shares) | 816 | 353 | 110 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ 3.97 | $ 10.77 | $ 11.90 |
Vested (in shares) | (144) | (118) | (77) |
Vested (in dollars per share) | $ 10.41 | $ 14.48 | $ 19.18 |
Forfeited (in shares) | (249) | (41) | (18) |
Forfeited (in dollars per share) | $ 7.93 | $ 0 | $ 0 |
Balance (in shares) | 800 | 377 | 183 |
Balance (in dollars per share) | $ 4.99 | $ 12.55 | $ 17.22 |
Note 13 - Stock-Based Compens_9
Note 13 - Stock-Based Compensation - Schedule of Weighted Average Assumptions (Details) | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | |
Expected life (months) (Month) | 6 months | 6 months | 6 months |
Risk-free interest rate | 0.12% | 2.37% | 2.26% |
Volatility | 82.00% | 54.00% | 50.00% |
Note 14 - Information Concern_3
Note 14 - Information Concerning Product Lines, Geographic Information, Accounts Receivable and Revenue Concentration (Details Textual) - USD ($) $ in Thousands | 12 Months Ended | |||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | ||
Revenue from Contract with Customer, Excluding Assessed Tax, Total | [1] | $ 8,634 | $ 10,310 | $ 12,629 |
JAPAN | ||||
Revenue from Contract with Customer, Excluding Assessed Tax, Total | $ 2,000 | $ 1,800 | $ 1,600 | |
JAPAN | Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | ||||
Concentration Risk, Percentage | 23.00% | 17.00% | 12.00% | |
CHINA | ||||
Revenue from Contract with Customer, Excluding Assessed Tax, Total | $ 1,100 | $ 1,800 | ||
CHINA | Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | ||||
Concentration Risk, Percentage | 11.00% | 15.00% | ||
UNITED STATES | ||||
Revenue from Contract with Customer, Excluding Assessed Tax, Total | $ 5,000 | $ 4,700 | $ 6,400 | |
UNITED STATES | Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | ||||
Concentration Risk, Percentage | 58.00% | 46.00% | 50.00% | |
Non-US [Member] | Assets, Total [Member] | Geographic Concentration Risk [Member] | ||||
Concentration Risk, Percentage | 4.00% | 7.00% | ||
[1] | New products include all products manufactured on 180 nanometer or smaller semiconductor processes, eFPGA IP license, QuickAI and SensiML AI software as a service (SaaS) revenues. Mature products include all products produced on semiconductor processes larger than 180 nanometer. |
Note 14 - Information Concern_4
Note 14 - Information Concerning Product Lines, Geographic Information, Accounts Receivable and Revenue Concentration - Schedule of Revenue by Product Line (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | ||
Total revenue | [1] | $ 8,634 | $ 10,310 | $ 12,629 |
New Products [Member] | ||||
Total revenue | [1] | 2,782 | 3,123 | 5,735 |
Mature Products [Member] | ||||
Total revenue | [1] | $ 5,852 | $ 7,187 | $ 6,894 |
[1] | New products include all products manufactured on 180 nanometer or smaller semiconductor processes, eFPGA IP license, QuickAI and SensiML AI software as a service (SaaS) revenues. Mature products include all products produced on semiconductor processes larger than 180 nanometer. |
Note 14 - Information Concern_5
Note 14 - Information Concerning Product Lines, Geographic Information, Accounts Receivable and Revenue Concentration - Schedule of Revenue by Shipment Destination (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | ||
Total revenue | [1] | $ 8,634 | $ 10,310 | $ 12,629 |
Asia Pacific [Member] | ||||
Total revenue | [2] | 2,096 | 3,049 | 4,905 |
Europe [Member] | ||||
Total revenue | 1,501 | 2,459 | 1,280 | |
North America [Member] | ||||
Total revenue | [3] | $ 5,037 | $ 4,802 | $ 6,444 |
[1] | New products include all products manufactured on 180 nanometer or smaller semiconductor processes, eFPGA IP license, QuickAI and SensiML AI software as a service (SaaS) revenues. Mature products include all products produced on semiconductor processes larger than 180 nanometer. | |||
[2] | Asia Pacific includes revenue from Japan of $2.0 million or 23% of total revenue in 2020 In 2019 revenue from Chinas was $1.1 million or 11% and Japan $1.8 million or 17%, respectively. In 2018, revenue from China was $1.8 million or 15% and Japan $1.6 million or 12%, respectively. | |||
[3] | North America includes revenue from the United States of $5.0 million or 58% of total revenue in 2020, $4.7 million or 46% of total revenue in 2019 and $6.4 million or 50% of total revenue in 2018. |
Note 14 - Information Concern_6
Note 14 - Information Concerning Product Lines, Geographic Information, Accounts Receivable and Revenue Concentration - Customer and Distributor Concentration (Details) - Customer Concentration Risk [Member] | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | |
Distributor "A" [Member] | Revenue Benchmark [Member] | |||
Concentration Risk, Percentage | 24.00% | 40.00% | 34.00% |
Distributor "A" [Member] | Accounts Receivable [Member] | |||
Concentration Risk, Percentage | 20.00% | ||
Distributor "C" [Member] | Revenue Benchmark [Member] | |||
Concentration Risk, Percentage | 15.00% | 13.00% | |
Distributor "C" [Member] | Accounts Receivable [Member] | |||
Concentration Risk, Percentage | 23.00% | ||
Distributor "E" [Member] | Revenue Benchmark [Member] | |||
Concentration Risk, Percentage | 19.00% | ||
Distributor "E" [Member] | Accounts Receivable [Member] | |||
Concentration Risk, Percentage | 12.00% | ||
Customer "B" [Member] | Revenue Benchmark [Member] | |||
Concentration Risk, Percentage | 10.00% | 13.00% | 12.00% |
Distributor "J" [Member] | Accounts Receivable [Member] | |||
Concentration Risk, Percentage | 31.00% | ||
Customer "E" [Member] | Revenue Benchmark [Member] | |||
Concentration Risk, Percentage | 10.00% | ||
Customer P [Member] | Accounts Receivable [Member] | |||
Concentration Risk, Percentage | 67.00% | ||
Customer "F" [Member] | Revenue Benchmark [Member] | |||
Concentration Risk, Percentage | 19.00% | ||
Customer Q [Member] | Accounts Receivable [Member] | |||
Concentration Risk, Percentage | 10.00% | ||
Customer G [Member] | Revenue Benchmark [Member] | |||
Concentration Risk, Percentage | 10.00% | ||
Customer "J" [Member] | Revenue Benchmark [Member] | |||
Concentration Risk, Percentage | 10.00% | ||
Customer "M" [Member] | Revenue Benchmark [Member] | |||
Concentration Risk, Percentage | 16.00% |
Note 15 - Commitments and Con_2
Note 15 - Commitments and Contingencies (Details Textual) - USD ($) | Jan. 03, 2021 | Dec. 29, 2019 |
Wafer Purchase Commitment [Member] | ||
Purchase Commitment, Remaining Minimum Amount Committed | $ 60,000 | $ 57,000 |
Goods and Services [Member] | ||
Purchase Obligation, Total | $ 692,000 |
Note 16 - Subsequent Events (De
Note 16 - Subsequent Events (Details Textual) - Heritage Bank of Commerce [Member] - Paycheck Protection Program [Member] - USD ($) $ in Millions | Jan. 26, 2021 | Jan. 03, 2021 | May 06, 2020 |
Debt Instrument, Face Amount | $ 1.2 | $ 1.2 | |
Subsequent Event [Member] | |||
Debt Instrument, Decrease, Forgiveness | $ 1.2 |
Schedule II - Valuation and Q_3
Schedule II - Valuation and Qualifying Accounts - Summary of Valuation Allowance (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 03, 2021 | Dec. 29, 2019 | Dec. 30, 2018 | |
Balance | $ 58,140 | $ 54,913 | $ 55,931 |
Additions at cost | 2,398 | 3,227 | 0 |
Deductions | 0 | 0 | (1,018) |
Balance | $ 60,538 | $ 58,140 | $ 54,913 |